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Abstract: In recent years, nanoparticles have been increasingly used in several industrial, 
consumer and medical applications because of their unique physico-chemical properties. 
However, in vitro and in vivo studies have demonstrated that these properties are also 
closely associated with detrimental health effects. There is a serious lack of information on 
the potential nanoparticle hazard to human health, particularly on their possible toxic 
effects on the endocrine system. This topic is of primary importance since the disruption of 
endocrine functions is associated with severe adverse effects on human health. 
Consequently, in order to gather information on the hazardous effects of nanoparticles on 
endocrine organs, we reviewed the data available in the literature regarding the endocrine 
effects of in vitro and in vivo exposure to different types of nanoparticles. Our aim was to 
understand the potential endocrine disrupting risks posed by nanoparticles, to assess their 
underlying mechanisms of action and identify areas in which further investigation is 
needed in order to obtain a deeper understanding of the role of nanoparticles as endocrine 
disruptors. Current data support the notion that different types of nanoparticles are capable 
of altering the normal and physiological activity of the endocrine system. However, a 
critical evaluation of these findings suggests the need to interpret these results with caution 
since information on potential endocrine interactions and the toxicity of nanoparticles is 
quite limited. 
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Abbreviations: 8-OHdG, 8-hydroxy-2-deoxyguanosine; ACTH, AdrenoCorticoTropic Hormone; 
ADP, Adenosine Diphosphate; Ag-HC-NPs, Hydrocarbon-coated silver Nanoparticles; Ag-NPs, Silver 
Nanoparticles; Ag-PS-NPs Polysaccharide-coated silver Nanoparticles; Al-NPs, Aluminum 
Nanoparticles; Al2O3-NPs, Aluminium Oxide Nanoparticles; ATP, Adenosine Triphosphate;  
Au-NPs, Gold Nanoparticles; C60HyFn, hydrated C60 fullerene; CB, Carbon Black; CB-NPs, Carbon 
Black Nanoparticles; CdS-QDs, Cadmium Sulfide Quantum Dots; CdS/CdTe capped-QDs, Cadmium 
Sulfide/Cadmium Tellurium capped-Quantum Dots; CdSe-core-QDs, Cadmium Selenium core 
Quantum Dots; CdTe-QDs, Cadmium Tellurium Quantum Dots; CdTe/ZnTe QDs, Cadmium 
Tellurium/Zinc Tellurium Quantum Dots; CeO2-NPs, Cerium Oxide Nanoparticles; Chg, Choriogenin; 
CHO, Chinese Hamster Ovary cells; CNTs, Carbon Nanotubes; COX-2, Cyclooxygenase-2;  
CrCl3-NPs, Chromium Chloride Nanoparticles; Cr-NPs, Chromium Nanoparticles; Cu-NPs, Copper 
nanoparticles; DA, Dopamine; DE-NPs, Diesel Exhaust Nanoparticles; DOPAC, 
dihydroxyphenylacetic acid; DSP, Daily Sperm Production; EDCs, Endocrine Disrupting Chemicals; 
EDPL, Endocrine Disruptor Priority List; ER, Estrogenic Receptor; ERK, extracellular  
signal-regulated kinase; EuOH3-NPs, Europium Hydroxied Nanoparticles; Eu2O3-NPs, Europium 
Oxide Nanoparticles; Fe3O4-NPs, Magnetic Iron Oxide Nanoparticles; FSH, Follicle Stimulating 
Hormone; FT3, free triiodothyronine; FT4, free thyroxine; GH, Growth Hormone; GnRH, 
Gonadotropin Releasing Hormone; HMG-CoA, 3-hydroxy-3-methylglutaryl-coenzyme A; HVA, 
HomoVanillic Acid; IGF-I, Insulin-like Growth Factor I; IR, Insulin Resistance; LDL-R, Low Density 
Lipoprotein Receptor; LH, Luteinizing Hormone; MAPKs, Mitogen-Activated Protein Kinases; 
MARCO, Macrophage Receptor with Collagenous structure; MN, Micro Nuclei; MnO-NPs, 
Manganese Oxide Nanoparticles; MoO3-NPs, Molybdenum Trioxide Nanoparticles; mPEG@Au-NP, 
ω-methoxy poly(ethylene glycol) capped gold-NPs; MTT, 3-(4,5-dimethyl-2-thiazol)-2,5-diphenyl-
2H-tetrazolium bromide; MWCNTs, Multi Walled Carbon Nanotubes; NPs, NanoParticles;  
NRDE-NPs, Nanoparticle-Rich Diesel Exhaust Nanoparticles; nSP, amorphous nanosilica particles; 
Ntera2, NT2, human testicular embryonic carcinoma cell line; P450 17α, Cytochrome P450 17α;  
P450 17β-HSD, Cytochrome P450 17β-HydroxySteroid Dehydrogenase; P450arom, Aromatase P450; 
P450scc, Cytochrome P450 side-chain cleavage; PBR, Peripheral-type Benzodiazepine Receptor; 
PEG, PolyEthilen-Glycol; PEG-NH2@Au-NP, ω-aminoethyl poly(ethylene glycol) capped gold-NPs; 
POP, Persistent Organic Pollutants; QDs, Quantum Dots; RLKI, Rana Larval Keratin Type I; ROS, 
Reactive Oxygen Species; SCE, Sister Chromatid Exchanges; SiCNWs, Silicon Carbide Nanowires;  
s-MWCNTs-PEG, synthesized functionalized MWCNTs with polyethylene glycol; SR-B1, Scavenger 
Receptor class B type 1; SSC, Spermatogonial Stem Cells; StAR, Steroidogenic Acute Regulatory 
protein; T2DM, Type 2 Diabetes Mellitus; TH, Thyroid Hormone; TiO2, Titanium Dioxide; TiO2-NPs, 
Titanium Dioxide nanoparticles; TRβ, Thyroid hormone Receptor β; TSH, Thyrotropic-Stimulating 
Hormone; UV, Ultra Violet; VTG, Vitellogenin; ZnO-NPs, Zinc Oxide Nanoparticles; ZnS, Zinc Sulfide; 
ZnS-QDs, Zinc Sulfide Quantum Dots. 
1. Introduction 
Over the past 50 years, epidemiological data have revealed a significant increase in the incidence 
and prevalence of a number of adverse effects on human health such as alterations in the development 
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and growth process, disorders of the immune and neurological systems, reduced fertility and the onset 
of some important diseases such as diabetes, obesity, breast, ovary, testicle and prostate cancer [1–3]. 
A possible explanation for the increase in these diseases lies in a growing exposure of workers and the 
general population to contaminants that may exert adverse effects on account of their action as 
endocrine disrupting chemicals (EDCs). In fact, most studies performed on EDCs have revealed that 
these compounds may play an important role in the onset of the aforementioned diseases by altering 
hormonal and homeostatic systems [4–10]. 
In 2002, the World Health Organization defined EDCs as ―an exogenous substance or mixture that 
alters functions of the endocrine system and consequently causes adverse health effects in an intact 
organism, or its progeny, or (sub)populations‖ [11]. The group of chemical substances that belongs to 
this category is highly heterogeneous: it includes industrial solvents and lubricants and their  
by-products, dioxins, bisphenol A, polychlorinated biphenyls, persistent organic pollutants (POP), 
plastic compounds, plasticizers, pesticides such as chlorinated insecticides, imidazoles and triazoles, 
pharmaceutical agents, chemical compounds that are widely used in cosmetics such as phthalates, and 
heavy metals such as cadmium, mercury, arsenic, lead, manganese and zinc [1,2,12]. EDCs are found 
in virtually all regions of the world and typical human exposure in the general population occurs via 
environmental contamination of the food chain, especially fresh water fish and meat, or through 
contact with contaminated environmental matrices, while occupational exposure can occur during the 
production, use and disposal of the aforementioned chemical substances [13,14]. Since exposure of the 
general population and workers to EDCs is ubiquitous and unavoidable, and the impact on human 
health due to the known or unknown effects of these chemicals on hormonal systems is great, there is 
an urgent need to increase efforts to identify the compounds that can behave as endocrine disruptors 
and to study their molecular mechanisms of action. The Endocrine Disruptor Priority List (EDPL), 
developed as part of the European Union strategy for EDCs, represents a practical attempt to achieve a 
wider and more comprehensive knowledge of these substances. It provides a list and categorization 
(see Table 1) of chemicals that are likely or suspected to be EDCs [15–18]. 
However, despite the studies carried out in recent years, current knowledge of EDCs is still limited 
and most research into this issue has concentrated on a few groups of chemical substances such as 
pesticides or POP, whereas data on a number of other xenobiotics that may act as EDCs is still scant 
and incomplete [1]. Therefore, to adequately address the issue of EDCs, it is our belief that the first 
step should be to identify all the possible compounds that can interfere and disrupt the homeostasis and 
regulatory mechanisms of the endocrine system. This provision is particularly urgent for those 
chemicals that have recently been used in workplaces and consumer products and whose toxicological 
profile has not yet been clearly and unequivocally defined. This is the case of nanoparticles (NPs). 
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Table 1. C
ategories, criteria of classifications and num
bers of chem
ical substances included in the Endocrine D
isrupter Priority list (ED
PL). 
The constitution and the integration of the ED
PL is carried out by a process of analysis w
hich consists of three steps. First of all, a w
orking list 
of suspected endocrine disruptors chem
icals is com
piled, based on the inform
ation provided by various organizations and on the analysis of 
the literature (step 1). Subsequently the available inform
ation is review
ed to identify those chem
icals that are m
ore relevant, in term
 of 
exposure, for both hum
ans and anim
als (step 2). Finally, the identified chem
icals are studied to determ
ine the strength of evidence for 
endocrine disruption and to enroll them
 in a specific category (step 3). A
ddition and rem
oval of chem
icals m
ay be required in response to 
either developm
ents in scientific know
ledge or changes in chem
ical usage patterns. 
Type of category 
Category 1 
Category 2 
Category 3a 
Category 3b 
References 
Criteria of 
classification 
A
t least one in vivo study 
providing clear evidence 
of endocrine disruption in 
an intact organism
 
Potential for endocrine 
disruption. In vitro data 
indicating potential for 
endocrine disruption in intact 
organism
s. A
lso includes effects 
in vivo that m
ay, or m
ay not be 
endocrine disruption-m
ediated. 
N
o scientific basis for 
inclusion in list. 
Endocrine disruption 
studies available but no 
indications of endocrine 
disruption effects. 
Substances w
ith no or 
insufficient data gathered 
Number of 
chemical 
substances in 
each category 
194 
125 
23 
86 
[15–18] 
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The International Organization for Standardization, in ISO/TS 27687, defines a nanoparticle as a 
nano-object with all three external dimensions in the size range of approximately 1–100 nm [19]. NPs 
can be subdivided into two main categories, engineered NPs that are intentionally produced with very 
specific properties or compositions, and incidental NPs, also known as ultrafine particles, that are 
typically byproducts of processes such as combustion and vaporization and working activities such as 
welding or grinding [20]. Reducing particle size increases surface area and modifies unique 
physicochemical properties such as high conductivity, strength, durability, and chemical reactivity [21]. 
Furthermore, because of their very small size, NPs can enter cells directly by penetrating the cell 
membrane and may cause interference of important cell functions. The internalization of NPs can 
occur in a variety of ways and particle size largely influences their endocytic processes and cellular 
uptake ability. Additionally, several experimental reports have shown that nanoparticle size also 
affects their internalization in terms of efficiency [22,23]. The industrial applications of NPs are very 
wide-ranging and include those that may lead to more efficient water purification, stronger and lighter 
building materials, increased computing power and speed, enhanced generation and conservation of 
energy, and new tools for the diagnosis and treatment of diseases [24]. In recent years, several in vitro 
studies have assessed the potential adverse health effects of NPs, pointing out their ability to produce 
reactive oxygen species (ROS), releasetoxic ions, disrupt electron/ion cell membrane transport activity 
and cause oxidative damage and lipid peroxidation, while the results of in vivo studies have shown that 
these materials can induce adverse effects on the respiratory, cardiovascular and nervous systems [25–27]. 
However, while nanotechnology and exposure to NPs are growing exponentially, research into their 
toxicological impact and possible hazard for human health and the environment is still fragmentary 
and largely incomplete. Consequently, even if nanotechnology and the commercialization of 
nanoenabled products and devices could help to address serious global problems (energy, 
transportation, pollution, health, medicine, and food), these benefits may not materialize unless a 
concerted effort is made to evaluate safety and health concerns regarding NPs. 
By summarizing the findings of the in vitro and in vivo studies that have investigated the effects of 
NPs on the endocrine system, this review aims to evaluate the potential role of different types of NPs 
as endocrine disruptors, focusing in particular on their molecular mechanisms of action and on the 
relationship between their physical and chemical properties and the induction of alterations in 
endocrine function. 
2. Impact of Endocrine Disrupting NPs on Reproductive Health 
Hormones play a key role in influencing the development of the reproductive system and 
subsequently in controlling its activities once developed. For this reason, most of the research carried 
out on EDCs in the last two decades has focused its attention on reproductive health. With regard to 
the male reproductive system, numerous in vitro and in vivo study findings have demonstrated that 
EDCs can exert a number of detrimental effects such as malformed reproductive tissue, poor semen 
quality (low sperm counts, low ejaculate volume, high number of abnormal sperm, low number of 
motile sperm), prostate diseases, testicular cancer, and other recognized abnormalities of male 
reproductive tissues [3,28]. There is also evidence that EDCs may interfere with female reproductive 
development and function causing adverse effects such as fibrocystic disease of the breast, polycystic 
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ovarian syndrome, endometriosis, uterine fibroids and pelvic inflammatory diseases, breast and 
reproductive organ tissue cancers and declining sex ratio [3,29].  
Recently, the results of studies conducted to assess the potential toxic effects of NPs, have 
suggested that some of these may pose risks to male and female reproductive health by altering normal 
testis and ovarian structure, spermatogenesis and sperm quality, oogenesis, follicle maturation and sex 
hormone levels.  
2.1. Effects of NPs on the Male Reproductive System 
Most of the adverse effects of NPs on male reproductive function are mainly due to modification of 
the testicular structure (see Figure 1), impairment of spermatogenesis and alteration in the biosynthetic 
and catabolic pathways of testosterone (see Table 2).  
Figure 1. Alterations and impairment of testicular structure induced by exposure to 
different types of NPs. Metal-based NPs, carbon-based NPs and nanoparticle-rich diesel 
exhaust (NRDE-NPs) were reported to induce changes in testicular histology of laboratory 
animals. Metal-based NPs (TiO2-NPs) induced the disruption of seminiferous tubules and 
decreased the number of Sertoli cells; Carbon-based NPs (carbon black-NPs, multi-walled 
carbon nanotubes) caused vacuolization of seminiferous tubules, seminiferous tubule 
damage and low cellular adhesion of seminiferous epithelia, partial disappearance or 
vacuolization of Sertoli cells, reduced thickness of the germinative layer, lower 
spermatogonia number, vasodilatation and hyperemia; NRDE-NPs induced degenerative 
and necrotic changes, interstitial edema, desquamation of the seminiferous epithelium, loss 
of germ cells and spermatozoa. 
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Table 2. Effects of N
Ps on the m
ale reproductive system
. 
Type of 
study 
Type and physico-chemical properties 
of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
Results 
References 
Alterations and impairment of testicular structure 
In vitro 
TiO
2 -N
Ps (25–70 nm
); C
B
-N
Ps (14 nm
); 
D
E-N
Ps 
Treatm
ent w
ith 0–1000 µg/m
L 
for 24 and 48 h 
M
ouse testis Leydig cell 
line TM
3 
x 
Internalization of N
Ps; 
x 
D
ose-dependent reduction of cell 
viability after 48-hour TiO
2 -N
P 
exposure. 
[30] 
In vitro 
75%
 rutile and 25%
 anatase TiO
2 -N
Ps 
(24.5 nm
) 
Treatm
ent w
ith 0.5–50 μg/m
L
 
for 4, 24 and 48 h 
R
TG
-2 cells 
x 
Significant cytotoxicity only at the 
highest concentration. 
[31] 
In vitro 
C
eO
2 -N
Ps (10 nm
 and 20–25 nm
) 
Treatm
ent w
ith 0-100 μg/m
L 
for 24 and 72 h 
RTG
-2 cells, derived from
 
rainbow
 trout 
(Oncorhynchus mykiss) 
gonadal tissue 
x 
N
o cytotoxic effects. 
[32] 
In vivo 
N
R
D
E-N
Ps—
A
verage of m
ode diam
eter 
and num
ber concentrations for low
, 
m
iddle and high doses w
ere 22.48, 26.13 
and 27.06 nm
; 2.27 × 10
5, 5.11 × 10
5 and 
1.36 × 10
6, respectively 
Inhalation exposure to low
 
(15.37), m
iddle (36.35) and 
high (168.84) µg/m
3 doses 
for 4, 8, or 12 w
eeks  
(5 h/day, 5 days/w
eek) 
Fischer F344 rats 
x 
Sem
iniferous tubules show
ed 
degenerative and necrotic changes, 
interstitial edem
a, desquam
ation of 
the sem
iniferous epithelium
, and 
loss of sperm
atozoa. 
[33] 
In vivo 
N
R
D
E-N
Ps—
A
verage of m
ode diam
eter 
and num
ber concentrations w
ere  
26.81 nm
 and 1.83 × 10
6, respectively 
Inhalation exposure to 
148.86 µg/m
3 for 5 h daily 
for 19 gestational days  
Pregnant Fischer F344 
rats  
x 
Loss of germ
 cells in the 
sem
iniferous tubules of m
ale 
offspring. 
[34] 
In vivo 
TiO
2 -N
Ps (anatase form
, particle size of 
25–70 nm
, surface area 20–25 m
2/g) 
Subcutaneous injections of 
100 µL of 1m
g/m
L solution 
on 4 gestational days 
Pregnant Slc:IC
R
 m
ice 
x 
D
isruption of sem
iniferous tubules; 
x 
D
ecreased num
bers of Sertoli cells. 
[35] 
In vivo 
C
B
-N
Ps (14, 56 and 95 nm
 w
ith a 
surface area of 300, 45 and 20 m
2/g, 
respectively) 
Intratracheal adm
inistration 
of 0.1 m
g/kg body w
eight 
for 10 tim
es every w
eek 
IC
R
 m
ice 
x 
Partial vacuolization of the 
sem
iniferous tubules; 
x 
The adverse effects depend on 
particle m
ass rather than particle 
num
ber. 
[36] 
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Table 2. Cont. 
Type of 
study 
Type and physico-chemical properties 
of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
Results 
References 
Alterations and impairment of testicular structure 
In vivo 
C
arboxylate-functionalized (diam
eter of 
20–30 nm
, length 0.5–2.0 µm
) and 
A
m
ine-functionalized (diam
eter of  
20–30 nm
, length 0.5–2.0 µm
) 
M
W
C
N
Ts 
M
ice w
ere random
ly divided 
into 12 groups (15-day single 
dose, 15-day m
ulti-dose,  
60-day m
ulti-dose, and  
90-day m
ulti-dose groups). 
M
ice w
ere given injections 
(5 m
g/kg) via the tail vein 
once (single dose) or every  
3 days for 5 tim
es 
B
A
LB
/c m
ice 
x 
Reduction in the thickness of the 
germ
inative layer;  
Reduced sperm
atogonia num
ber;  
Partial disappearance or 
vacuolization of Sertoli cells;  
Induction of oxidative stress. 
[37] 
In vivo 
C
B
-N
Ps (14 nm
) 
Intratracheal adm
inistration 
of 0.2 m
g/kg body w
eight on 
days 7 and 14 of gestation 
Pregnant IC
R
 m
ice  
x 
Partial vacuolization of 
sem
iniferous tubules;  
Reduction of cellular adhesion of 
sem
iniferous epithelia. 
[38] 
In vivo 
m
PEG
@
A
u-N
P and PEG
-N
H
2 @
A
u-N
P 
(14 nm
) 
Intravenous injection of  
45 and 225 m
g/kg of 
m
PEG
@
A
u-N
P and  
45 m
g/kg of PEG
-N
H
2 @
 
A
u-N
P at 48 h intervals for  
5 days 
IC
R
 m
ice 
x 
Penetration and accum
ulation of 
N
Ps in the testes;  
N
o testicular m
orphological 
changes;  
N
o germ
 cell apoptosis. 
[39] 
In vivo 
A
m
orphous silica particles (nSP70,  
70-nm
 diam
eter; nSP300,  
300-nm
 diam
eter) 
Intravenous injection of  
0.4 and 0.8 m
g of nSP70 
B
A
LB
/c m
ice 
x 
nSP70 can penetrate the blood-
testis barrier and the nuclear 
m
em
branes of sperm
atocytes 
w
ithout producing apparent 
testicular injury. 
[40] 
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Table 2. Cont. 
Type of 
study 
Type and physico-chemical properties 
of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
Results 
References 
Alterations and impairment of spermatogenesis 
In vitro 
Fullerenol 
Treatm
ent w
ith fullerenol  
(1, 10 and 100 µm
ol) for 3 h. 
Epididym
al sperm
 
sam
ples collected from
 
the fresh epididym
is of 
adult goats 
x 
Protective effect, by increasing the 
activities of antioxidant enzym
es 
and decreasing lipid peroxidation, 
on the potential oxidative stress 
dam
age on sperm
atozoa. 
[41] 
In vitro 
Silver (15 nm
), m
olybdenum
 (30 nm
), 
and alum
inum
 (30 nm
) 
Treatm
ent w
ith 5, 10, 25, 50, 
and 100 µg/m
L culture 
m
edium
 for 48 h 
C
18-4 sperm
atogonial 
stem
 cell line 
x 
concentration-dependent toxicity 
for all types of particles tested;  
Silver nanoparticles w
ere the 
m
ost toxic w
hile m
olybdenum
 
trioxide (M
oO
3 ) nanoparticles 
w
ere the least toxic. 
[42] 
In vitro 
M
agnetic iron oxide N
Ps (Fe3O
4 -N
Ps) 
coated w
ith poly(vinyl alcohol) 
Treatm
ent w
ith 7.35 m
M
 for 
80 m
in and 4 h 
B
ovine sperm
 cells 
x 
N
o effects on the m
otility and the 
ability to undergo the acrosom
e 
reaction. 
[43] 
In vitro 
Eu
2 O
3 -N
Ps (30 ± 10 nm
); 
EuO
H
3 -N
Ps conjugated w
ith polyvinyl 
alcohol or polyvinyl piyrolidone  
(15.4 ± 3 nm
 and 9.3 ± 3 nm
, 
respectively) 
1 m
L of w
ashed sperm
 cells 
w
as incubated for 24 h at  
39 °C w
ith 2.5 m
g/m
L of 
Eu
2 O
3 -N
Ps or of EuO
H
3 -N
Ps 
B
ovine sperm
 cells 
x 
Loss of bovine sperm
atozoa 
m
otility after exposure to  
Eu
2 O
3 -N
Ps;  
N
o effects on m
otility and the 
ability to undergo acrosom
e 
reaction after exposure to  
EuO
H
3 -N
Ps. 
[44] 
In vitro 
TiO
2 -N
Ps and ZnO
-N
Ps (40–70 nm
) 
Treatm
ent w
ith  
3.73–59.7 µg/m
L of  
TiO
2 -N
Ps and  
11.5–93.2 µg/m
L of  
ZnO
-N
Ps 
H
um
an sperm
atozoa 
x 
Concentration - dependent 
induction of sperm
 D
N
A
 dam
age. 
[45] 
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Table 2. Cont. 
Type of 
study 
Type and physico-chemical properties 
of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
Results 
References 
Alterations and impairment of spermatogenesis 
In vitro 
A
u-N
Ps (9 nm
) 
A
nalyses w
ere conducted on 
a m
ixture of 500 µL of  
A
u-N
Ps (44 ppm
) solution 
and sem
en 
H
um
an sperm
atozoa 
x 
25%
 of sperm
 w
ere not m
otile;  
Penetration of A
u-N
Ps into the 
sperm
 head and tails;  
Fragm
entation of sperm
. 
[46] 
In vitro 
H
ydrocarbon-coated silver (A
g-H
C
) 
nanoparticles of 15, 25, and 80 nm
 
diam
eters and Polysaccharide-coated 
silver (A
g-PS) nanoparticles 
of 10, 25–30, and 80 nm
 diam
eters 
Treatm
ent w
ith 5, 10, 25, 50, 
and 100 µg/m
L culture 
m
edium
 for 24 h 
C
18-4 sperm
atogonial 
stem
 cell line 
x 
A
t concentrations ≥ 10 m
g/m
L, 
A
g-N
Ps induced a significant 
decline in SSC
 proliferation, 
w
hich w
as also dependent on 
their size and coating;  
A
t a concentration of 10 m
g/m
L, 
A
g-N
Ps specifically interact w
ith 
Fyn kinase dow
nstream
 of R
et 
and im
pair SSC
 proliferation. 
[47] 
In vitro 
A
u-N
Ps (5–65 nm
) 
Treatm
ent w
ith 0.5–50 µM
 
for 2 h 
B
ovine sperm
atozoa 
x 
22%
 loss in sperm
 m
otility after 
exposure to the highest dose. 
[48] 
In vitro 
A
u-N
Ps (~2.5 nm
 in diam
eter) 
Treatm
ent w
ith 
concentrations of 0.5 × 10
15 
or 1 × 10
15 particles/m
L for 
20 and 40 m
in 
Epididym
al sperm
 
sam
ples collected from
 
the epididym
is of hybrid 
m
ice C
B
A
 × C
57B
1/6 
x 
A
u-N
Ps possess sperm
atotoxicity, 
causing an inhibition of chrom
atin 
decondensation process  
in gam
etes. 
[49] 
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Table 2. Cont. 
Type of 
study 
Type and physico-chemical properties 
of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
Results 
References 
Alterations and impairment of spermatogenesis 
In vitro 
A
g-N
Ps (65 nm
) 
A
liquots of total sem
en w
ere 
incubated at 37 °C
 for  
60 m
in and 120 m
in at the 
concentration 
of 125, 250 and 500 µM
 
Sem
en sam
ples obtained 
from
 10 healthy donors 
x 
D
ecline in sperm
 m
otility and 
viability even at the low
est 
concentration used;  
The cytotoxic effect occurs in a 
dose dependent m
anner;  
Sperm
 viability w
as alw
ays 
higher than the percentage of 
sperm
 m
otility m
eaning that 
sperm
atozoa w
ere viable but 
im
m
otile. 
[50] 
In vitro 
A
g-N
Ps (20 nm
)  
and TiO
2 -N
Ps (21 nm
) 
C
ells w
ere exposed for 24, 
48 and 72 h to 10, 50 and 
100 µg/m
L, equivalent to  
7.8, 15.6 and 31 µg/cm
2, 
respectively 
N
tera2 (N
T2, hum
an 
testicular em
bryonic 
carcinom
a cell line) and 
prim
ary testicular cells 
from
 C
57B
L6 m
ice of 
w
ild type (W
T) and 8-
oxoguanine D
N
A
 
glycosylase knock-out 
(K
O
, m
O
gg1−/−) 
genotype 
x 
A
g-N
Ps are m
ore cytotoxic and 
cytostatic com
pared to TiO
2 -N
Ps, 
causing apoptosis, necrosis and 
decreased proliferation in a 
concentration- and tim
e-dependent 
m
anner. 
[51] 
In vivo 
TiO
2 -N
Ps 
Intraperitoneal injection of 
200 and 500 µg/kg every 
other day for five tim
es 
IC
R
 m
ice 
x 
N
o significant changes in the low
 
dose group;  
Reduced sperm
 density and 
m
otility, increased sperm
 
abnorm
ality and germ
 cell 
apoptosis in the high dose group. 
[52] 
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Table 2. Cont. 
Type of 
study 
Type and physico-chemical properties 
of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
Results 
References 
Alterations and impairment of spermatogenesis 
In vivo 
TiO
2 -N
Ps (anatase form
, particle size of 
25–70 nm
, surface area 20–25 m
2/g) 
Subcutaneous injections of 
100 µL of 1 m
g/m
L solution 
Pregnant Slc: IC
R
 m
ice 
x 
D
ecrease of D
SP and epidydim
al 
sperm
 m
otility in m
ale offspring.  
[35] 
In vivo 
C
B
-N
Ps (14, 56 and 95 nm
 w
ith a 
surface area of 300, 45 and 20 m
2/g, 
respectively) 
Intratracheal adm
inistration 
of 0.1 m
g/kg body w
eight 
every w
eek for 10 tim
es 
IC
R
 m
ice 
x 
The D
SP decreased by 33%
 in 
the 14 nm
 C
B
 group, by 33%
 in 
the 56 nm
 C
B
 group and by 23%
 
in the 95 nm
 C
B
 group. 
[36] 
In vivo 
C
arboxylate-functionalized (diam
eter of 
20–30 nm
, length 0.5–2.0 µm
) and 
A
m
ine-functionalized (diam
eter of  
20–30 nm
, length 0.5–2.0 µm
) 
M
W
C
N
Ts 
M
ice w
ere random
ly divided 
into 12 groups (15-day single 
dose, 15-day m
ulti-dose,  
60-day m
ulti-dose, and  
90-day m
ulti-dose groups). 
M
ice w
ere given injections 
(5 m
g/kg) via the tail vein 
once (single dose) or  
every 3 days for 5 tim
es 
B
A
LB
/c m
ice 
x 
N
o alterations in the total sperm
 
concentration, m
otility, percentage 
of abnorm
al sem
en and loss of 
acrosom
e integrity w
ere detected in 
the treated m
ice. 
[37] 
In vivo 
C
B
-N
Ps (14 nm
) 
Intratracheal adm
inistration 
of 0.2 m
g/kg body w
eight of 
C
B
-N
Ps on days 7 and 14 of 
gestation 
Pregnant fem
ale IC
R
 
m
ice 
x 
The D
SP in the fetal carbon 
nanoparticle-exposed m
ice 
decreased by 47%
 at the age of  
5 w
eeks, by 34%
 at the age of  
10 w
eeks, and by 32%
 at the age 
of 15 w
eeks. 
[38] 
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Table 2. Cont. 
Type of 
study 
Type and physico-chemical properties 
of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
Results 
References 
Alterations and impairment of spermatogenesis 
In vivo 
C
60  fullerene (3–36 nm
) 
R
ats received distilled w
ater 
containing aqueous solutions 
of C
60 H
yFn at concentration 
of 4~µg/kg daily for 5 w
eeks 
H
ealthy and 
streptozotocin-induced 
diabetic m
ale W
istar 
albino rats 
x 
N
o significant toxic effects in 
testicular tissues w
ere observed;  
In the diabetic rats, C
60  fullerene 
increased sperm
 m
otility, 
epididym
al sperm
 concentration 
and decreased the abnorm
al 
sperm
 rate, show
ing an im
portant 
anti-oxidant activity. 
[53] 
In vivo 
D
im
ercaptosuccinic acid coated  
Fe
3 O
4 -N
Ps (3–9 nm
) 
Intraperitoneal injection in a 
single dose of 50, 100, 200 
and 300 m
g/kg 
Fem
ale pregnant  
B
alb/C
 m
ice 
x 
In m
ale infants of m
others 
treated w
ith doses higher than  
50 m
g/kg a significant decrease 
in sperm
atogonia, sperm
atocytes, 
sperm
atids and m
ature sperm
 
w
as observed. 
[54] 
In vivo 
TiO
2 -N
Ps (33.2 ± 16.7 nm
) 
A
dm
inistration by oral 
gavage of 40, 200 and  
1000 m
g/kg w
ith volum
e of 
suspension 10 m
L/kg of 
m
ouse w
eight 
M
ale C
B
A
xB
6 m
ice 
x 
Increase of the testis apoptotic 
index and of the frequency of 
round sperm
atidis w
ith tw
o or 
m
ore nuclei. 
[55] 
In vivo 
A
g-N
Ps w
ith a nom
inal diam
eter of  
20 ± 5 nm
 
Intravenous injection w
ith a 
single dose (5 m
g/kg or  
10 m
g/kg) of A
g-N
Ps 
W
istar rats 
x 
D
ecreased epididym
al sperm
 
count and increased D
N
A
 
dam
age in germ
 cells at 24 h 
post-exposure;  
The m
ost severe adverse effects 
w
ere caused by the sm
aller 
particles. 
[56] 
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Table 2. Cont. 
Type of 
study 
Type and physico-chemical properties 
of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
Results 
References 
Alterations and impairment of spermatogenesis 
In vivo 
m
PEG
@
A
u-N
P and PEG
-N
H
2 @
A
u-N
P 
(14 nm
) 
Intravenous injection of 45 and 
225 m
g/kg of m
PEG
@
A
u-N
P 
and 45 m
g/kg of  
PEG
-N
H
2 @
A
u-N
P at 48 h 
intervals for 5 days 
IC
R
 m
ice 
x 
N
o abnorm
alities in term
s of 
irregular shapes or form
s w
ere 
observed in the sperm
 collected 
from
 the cauda epididym
is of 
anim
als. 
[39] 
In vivo 
N
ude short M
W
C
N
Ts (50–200 nm
) and 
synthesized functionalized M
W
C
N
Ts 
w
ith polyethylene glycol (PEG
)  
(s-M
W
C
N
Ts-PEG
). 
Intravenous adm
inistration 
w
ith a single dose of  
100 μg/kg body w
eight 
K
unm
ing m
ice 
x 
N
o toxicity of these nanotubes 
on m
ale m
ouse sperm
 production 
or m
utagenesis in the long term
 
exposure w
as observed. 
[57] 
In vivo 
Pow
der of nanoparticulate TiO
2  (prim
ary 
particle size w
as 20.6 nm
, in the 
exposure atm
osphere the particle num
ber 
concentration w
as 1.7 × 10
6 particles/cm
3 
and the m
ajor particle size m
ode w
as  
97 nm
); nanosized C
B
 (particle size w
as 
14 nm
) 
M
ice w
ere exposed by w
hole 
body inhalation, 1 h/day from
 
gestation day 8 to18, to 42 
m
g/m
3 of aerosolized pow
der 
of nanoparticulate TiO
2 ; m
ice 
w
ere intratracheally instilled 
four tim
es during gestation, 
(days 7, 10, 15 and 18) w
ith 
67 μg/anim
al of nanosized C
B 
Pregnant fem
ale 
C
57B
L/6J m
ice 
x 
TiO
2 -N
Ps tended to reduce sperm
 
count in the F1 generation;  
There w
as no effect on sperm
 
production in the F2 generation 
originating after TiO
2 -N
Ps 
exposure;  
F2 offspring, w
hose fathers w
ere 
prenatally exposed to CB-N
Ps, 
show
ed low
ered sperm
 production. 
[58] 
Disruption of normal levels of sex hormones 
In vitro 
TiO
2 -N
Ps (25–70 nm
); C
B
-N
Ps (14 nm
); 
D
E-N
Ps 
Treatm
ent w
ith 0–1000 µg/m
L 
for 24 and 48 h 
M
ouse testis Leydig cell 
line TM
3 
x 
Induction of StA
R
 gene 
expression. 
[30] 
In vitro 
N
R
D
E-N
Ps 
M
ice w
ere exposed to 
152.01 µg/m
3 of N
R
D
E-N
Ps 
for 8 w
eeks 
Interstitial testicular 
cells, dissected from
 
m
ale C
57B
L/Jcl m
ice 
x 
Testosterone production in 
interstitial testicular cells w
as 
significantly increased both w
ith 
and w
ithout hum
an chorionic 
gonadotropin stim
ulus. 
[59] 
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Table 2. Cont. 
Type of 
study 
Type and physico-chemical properties 
of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
Results 
References 
Disruption of normal levels of sex hormones 
In vivo 
N
R
D
E-N
Ps—
A
verages of m
ode 
diam
eter and num
ber concentrations for 
low
, m
iddle and high doses w
ere 22.48, 
26.13 and 27.06 nm
; 2.27 × 10
5,  
5.11 × 10
5 and 1.36 × 10
6, respectively 
Inhalation exposure to low
 
(15.37), m
iddle (36.35) and 
high (168.84) µg/m
3 doses 
for 4, 8, or 12 w
eeks  
(5 h/day, 5 days/w
eek) 
Fischer F344 rats 
x 
Exposure to low
 and m
edium
 
concentrations of N
RD
E-N
Ps 
significantly increased plasm
a and 
testicular testosterone, w
hereas 
exposure to a high concentration 
did not (inverted-U
 dose-response);  
N
o alterations in LH
 and FSH
 
production w
ere observed. 
[33] 
In vivo 
N
R
D
E-N
Ps—
A
verages of m
ode 
diam
eter and num
ber concentrations 
w
ere 26.81 nm
 and 1.83 × 10
6, 
respectively 
Inhalation exposure to 
148.86 µg/m
3 for 5 h daily 
for 19 gestational days  
Pregnant Fischer F344 
rats and m
ale offspring 
x 
D
ecreased FSH
 and testosterone 
and increased ir-inhibin levels 
w
ere observed in the offspring.  
[34] 
In vivo 
N
R
D
E-N
Ps—
A
verages of m
ode 
diam
eter and num
ber concentrations for 
low
, m
iddle and high doses w
ere 22.48, 
26.13 and 27.06 nm
; 2.27 × 10
5,  
5.11 × 10
5 and 1.36 × 10
6, respectively 
Inhalation exposure to low
 
(15.37), m
iddle (36.35) and 
high (168.84) µg/m
3 doses 
for 4, 8, or 12 w
eeks  
(5 h/day, 5 days/w
eek) 
Fischer F344 rats 
x 
Low
 and m
edium
 exposure to 
N
R
D
E-N
Ps significantly 
increased StA
R
- and  
P450scc-m
R
N
A
 and their protein 
expressions in the testis of rats, 
in w
hich the elevation pattern 
w
as very sim
ilar to that of 
plasm
a testosterone levels. 
[60] 
In vivo 
C
B
-N
Ps (14, 56 and 95 nm
 w
ith  
a surface area of 300, 45 and 20 m
2/g, 
respectively) 
Intratracheal adm
inistration 
of 0.1 m
g/kg body w
eight 
for 10 tim
es every w
eek 
IC
R
 m
ice 
x 
Increased testosterone levels. 
[36] 
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Table 2. Cont. 
Type of 
study 
Type and physico-chemical properties 
of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
Results 
References 
Disruption of normal levels of sex hormones 
In vivo 
C
arboxylate-functionalized (diam
eter of 
20–30 nm
, length 0.5–2.0 µm
) and 
A
m
ine-functionalized (diam
eter of  
20–30 nm
, length 0.5–2.0 µm
) 
M
W
C
N
Ts 
M
ice w
ere random
ly divided 
into 12 groups (15-day single 
dose, 15-day m
ulti-dose,  
60-day m
ulti-dose, and  
90-day m
ulti-dose groups). 
M
ice w
ere given injections 
(5 m
g/kg) via the tail vein 
once (single dose) or every  
3 days for 5 tim
es 
B
A
LB
/c m
ice 
x 
M
W
C
N
T exposure did not alter 
plasm
a levels of testosterone, 
LH
, and FSH
. 
[37] 
In vivo 
C
B
-N
Ps (14 nm
) 
Intratracheal adm
inistration 
of 200 µg of C
B
-N
Ps on 
days 7 and 14 of gestation 
Pregnant fem
ale  
IC
R
 m
ice 
x 
N
o significant increase in 
testosterone levels w
as observed in 
fetal carbon nanoparticle- exposed 
m
ice. 
[38] 
In vivo 
N
R
D
E-N
Ps 
M
ice w
ere exposed to 
152.01 µg/m
3 of N
R
D
E-N
Ps 
for 8 w
eeks 
C
57B
L/Jcl m
ice 
x 
Increased levels of testosterone;  
This result w
as related to the 
enhanced expression of genes 
involved in testicular cholesterol 
synthesis, such as H
M
G
-C
oA
, 
LD
L-R
, SR
-B
1, PB
R
, P450scc, 
P450 17α, and 17β-H
SD
. 
[59] 
In vivo 
m
PEG
@
A
u-N
P and PEG
-N
H
2 @
A
u-N
P 
(14 nm
) 
Intravenous injection of  
45 and 225 m
g/kg of 
m
PEG
@
A
u-N
P and  
45 m
g/kg of PEG
-N
H
2 @
 
A
u-N
P at 48 h intervals for  
5 days 
IC
R
 m
ice 
x 
The adm
inistration of  
PEG
-N
H
2@
A
u-N
P caused a 
significant increase in 
testosterone levels;  
N
o alterations in LH
 and FSH
 
plasm
a values w
ere detected. 
[39] 
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Table 2. Cont. 
Type of 
study 
Type and physico-chemical properties 
of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
Results 
References 
Disruption of normal levels of sex hormones 
In vivo 
N
R
D
E-N
Ps 
Inhalation exposure to low
 
(38 ± 3 µg/m
3) and high 
(149 ± 8 µg/m
3) N
R
D
E-N
P 
concentrations 
Fischer F344 rats 
x 
H
igh and low
 N
R
D
E-N
P 
concentrations increased plasm
a 
and testicular testosterone levels. 
[61] 
A
g-H
C
-N
Ps, 
H
ydrocarbon-coated 
silver 
N
anoparticles; 
A
g-N
Ps, 
Silver 
N
anoparticles; 
A
g-PS-N
Ps 
Polysaccharide-coated 
silver 
N
anoparticles; 
A
u-N
Ps, 
G
old 
N
anoparticles; C
60 H
yFn, hydrated C
60  fullerene; C
B
, C
arbon B
lack; C
B
-N
Ps, C
arbon B
lack N
anoparticles; C
eO
2 -N
Ps, C
erium
 O
xide N
anoparticles; D
E-N
Ps, D
iesel 
Exhaust N
anoparticles; D
SP, D
aily Sperm
 Production; Eu
2 O
3 -N
Ps, Europium
 O
xide N
anoparticles; EuO
H
3 -N
Ps, Europium
 H
ydroxied N
anoparticles; Fe
3 O
4 -N
Ps, Iron 
O
xide N
anoparticles; FSH
, Follicle Stim
ulating H
orm
one; H
M
G
-C
oA
, 3-hydroxy-3-m
ethylglutaryl-coenzym
e A
; LD
L-R
, Low
 D
ensity Lipoprotein R
eceptor; LH
, 
Luteinizing H
orm
one; m
PEG
@
A
u-N
P, ω-m
ethoxy poly(ethylene glycol) capped gold-N
Ps; M
oO
3 , m
olybdenum
 trioxide; M
W
C
N
Ts, M
ulti W
alled C
arbon N
anotubes; 
N
R
D
E-N
Ps, N
anoparticle-R
ich D
iesel Exhaust N
anoparticles; nSP, am
orphous nanosilica particles; P450 17α, C
ytochrom
e P450 17α; P450 17β-H
SD
, C
ytochrom
e P450 
17β-H
ydroxySteroid D
ehydrogenase; P450scc, C
ytochrom
e P450 side-chain cleavage; PB
R
, Peripheral-type B
enzodiazepine R
eceptor; PEG
-N
H
2@
A
u-N
P, ω-am
inoethyl 
poly(ethylene glycol) capped gold-N
Ps; s-M
W
C
N
Ts-PEG
, synthesized functionalized M
W
C
N
Ts w
ith polyethylene glycol; SR
-B
1, Scavenger R
eceptor class B
 type 1; 
SSC
, Sperm
atogonial Stem
 C
ells; StA
R
, Steroidogenic A
cute R
egulatory protein; TiO
2 , Titanium
 D
ioxide; TiO
2 -N
Ps, Titanium
 D
ioxide nanoparticles; ZnO
-N
Ps, Zinc 
O
xide N
anoparticles. 
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To investigate damage caused by NPs to testicular constituent cells, three in vitro studies evaluated 
the cytotoxic effects of different types of NPs on mouse Leydig TM3 cells and on the RTG-2 cell line. 
The exposure of TM3 cells to increasing concentrations (0–1000 µg/mL) of titanium dioxide NPs 
(TiO2-NPs) induced a remarkable and dose-dependent reduction of cell viability [30]. Similarly, in the 
RTG-2 cell line, exposure to 50 μg/mL (the highest concentration used in this study) of TiO2-NPs 
produced a significant cytotoxicity [31]. In contrast, carbon black NPs (CB-NPs) and diesel exhaust 
NPs (DE-NPs) caused only slight cytotoxicity in TM3 cells [28], while cerium oxide NPs (CeO2-NPs) 
proved non-cytotoxic on the RTG-2 cell line [32]. With regard to these in vitro studies it should be 
noted that the different degree of observed cytotoxicity may depend on several factors. In fact the 
effect on the cytotoxicity of cells varies with different NPs and different cells, presumably because of 
the differing sensibility of cells and the varying sizes, doses, components and physico-chemical 
properties of the NPs. Furthermore, even when the experimental conditions (cell lines, particle size and 
concentrations) are quite similar for example in the studies of Vevers et al. [31] and Rosenkranz et al. [32], 
the conflicting results could be explained by taking into account the mode of toxicity that may be very 
different for the various metal oxide NPs, as has been shown for inflammogenic responses [62]. 
Several in vivo studies (see Table 2) have demonstrated that carbon-based NPs, nanoparticle-rich 
diesel exhaust (NRDE-NPs) and metal-based NPs are able to induce changes in the testicular histology 
of laboratory animals. These alterations appeared of great importance since they could affect the 
―micro-environment‖ required for a correct reproductive function. Intratracheal administration of a  
0.1 mg/kg body weight dose of different CB-NPs caused partial vacuolization of the seminiferous 
tubules in ICR mice [36]. The same research group reported clear seminiferous tubule damage and low 
cellular adhesion of seminiferous epithelia in the offspring of this animal model after prenatal exposure 
to 0.2 mg/kg body weight of CB-NPs, demonstrating in utero developmental sensitivity to the CB-NP 
endocrine disrupting insult [38]. Another type of carbon-based NP induced similar damage (reduced 
thickness of the germinative layer, lower spermatogonia number, partial disappearance or 
vacuolization of Sertoli cells, vasodilatation and hyperemia) in the testes of BALB/c mice treated with 
intravenous injections (5 mg/kg/dose) of amine- or carboxylate-functionalized Multi Walled Carbon 
Nanotubes (MWCNTs) [37]. Severe adverse effects on seminiferous tubules, such as degenerative and 
necrotic changes, interstitial edema, desquamation of the seminiferous epithelium, and loss of 
spermatozoa were also observed in Fischer rats exposed via inhalation to different doses (15.37, 36.35 
and 168.84 µg/m3) of NRDE-NPs [33]. The findings of a similar study, carried out in pregnant rats 
treated with 148.86 µg/m3 of the same NPs, detected the loss of germ cells in the seminiferous tubules 
of offspring [34]. Since carbon-based NPs of different types and particle sizes, administered to animals 
by different routes and in a variety of exposure doses caused similar damages, these NPs may share a 
common mechanism of action that could be the induction of oxidative stress as is suggested by the 
findings of Bai et al. [37] who observed an increase in malondialdehyde levels 15 days after treatment. 
With regard to the testicular morphological alterations in offspring, the pre-natal exposure to  
TiO2-NPs of Slc:ICR mice, subcutaneously injected with 100 μg/kg body weight/day, also led to 
disruption of seminiferous tubules and lower numbers of Sertoli cells in 6 week-old pups [35]. It is 
worth noting that in this study TiO2-NPs were detected in Leydig cells, Sertoli cells and spermatids of 
the testis of offspring at both 4 days and 6 weeks of age suggesting a direct NP induced insult on the 
reproductive organ. In contrast, studies carried out by Yoshida et al. [38] and Li et al. [34] failed to 
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detect NPs in the testis of pups prenatally exposed to CB-NPs and NRDE-NPs, respectively. 
Consequently, no definitive conclusion can be reached concerning the role NPs may play in causing 
direct damage to this organ. The damage observed may be related to accumulation of NPs in the 
placenta, thereby resulting in malnutrition of the foetus. However, the Authors observed no significant 
differences in body and organ weights between the exposed and control groups in either study. 
In contrast with the previous studies, the intravenous administration of 45 and 225 mg/kg  
ω-methoxy and 45 mg/kg ω-aminoethyl poly(ethylene glycol) capped Au-NPs (mPEG@Au-NP and 
PEG-NH2@Au-NP, respectively) in ICR mice did not cause testicular morphological changes or germ 
cell apoptosis, even if these NPs had accumulated in mouse testes, passed through the blood-testis 
barrier, and entered germ cells [39]. Similarly, Morishita et al. [40] demonstrated that amorphous silica 
NPs were able to penetrate the blood-testis barrier and be internalized in cytoplasm and the nuclei of 
spermatocytes but did not induce any apparent testicular injury in BALB/c mice intravenously injected 
with 0.8 mg of the aforementioned NPs. Surprisingly, although the total doses of nanomaterials that 
were administered in these studies were significantly higher than the total dose used in the MWCNT 
report [37], no testicular morphological alterations were observed. These findings may be due to the 
different physico-chemical characteristics of the NPs studied, particulalrly their chemical composition, 
shape and surface functionalizations, since these properties significantly affect the toxicological profile 
of NPs. Morishita et al. [40] have suggested that NP testicular distribution and penetration may depend 
on the type of material but also on surface modifications as demonstrated by a higher accumulation  
in the testes of PEG-NH2@Au-NP compared to mPEG@Au-NP. Concerning alterations in 
spermatogenesis (see Table 2), several in vitro studies have investigated the potential toxic effects of 
different types of NPs (mainly metal- and carbon-based NPs) on spermatozoa and their maturation 
process, principally by evaluating cytotoxicity, DNA damage and modifications in sperm quality 
parameters. Significant dose-dependent cytotoxicity was observed in the C18-4 spermatogonial stem 
cell line exposed to concentrations ranging from 0 to 100 µg/mL of silver NPs (Ag-NPs), molybdenum 
trioxide NPs (MoO3-NPs) and aluminum NPs (Al-NPs) [42]. The Ag-NPs were found to be the most 
toxic. Interestingly, when evaluating the cytotoxicity of several Ag-NPs with different diameters and 
coatings, the same Authors demonstrated that smaller and hydrocarbon- coated Ag-NPs induced a 
greater reduction in cell viability [47]. Furthermore, Ag-NPs have been shown to interact with proteins 
and potentially block signaling by binding to glial cell line-derived neurotrophic factor or its receptor 
Ret, thereby eliminating ligand receptor interaction, or by interfering with intracellular signaling 
molecules. The same metal-based NPs and TiO2-NPs showed a dose and time dependent cytotoxic 
effect also in the Ntera2 (NT2, human testicular embryonic carcinoma) cell line and in primary 
testicular cells obtained from wild type (WT) C57BL6 mice and 8-oxoguanine DNA glycosylase 
knock-out (Ogg1−/−) (KO) genotype treated with concentrations of NPs ranging from 0 to  
100 μg/mL [51]. Similar results were obtained by Terzuoli et al. [50] in human spermatozoa  
treated with different doses (0–500 µM) of Ag-NPs. However, the toxic effects of NPs on germ cells 
were not confirmed by the studies of Rafeeqi and Kaul and Murugan et al. [41,63] who demonstrated a 
clear biocompatibility between carbon nanotubes (CNTs) and spermatogonial cells and a fullerenol 
protective effect on the potential oxidative stress damage on spermatozoa, respectively. Once again the 
findings of these studies demonstrated the importance of different NP physico-chemical properties in 
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determining the toxic effects. In fact, they show the importance of NP size, functionalization and 
chemical composition in influencing the biologic response of cell systems [41,42,47,63]. 
With regard to DNA damage, the treatment of mouse epididymal sperm with 0.5 × 1015 or  
1.0 × 1015 particles/mL of gold nanoparticles (Au-NPs) resulted in inhibition of the chromatin 
decondensation process in gametes [49]. Unfortunately, this adverse effect was not observed by the 
same research group in a subsequent study conducted on mature gametes [64]. However, a 
concentration-dependent induction of sperm DNA damage was also observed in human spermatozoa 
treated with different doses of TiO2-NPs (3.73–59.7 µg/mL) and Zinc Oxide nanoparticles (ZnO-NPs) 
(11.5–93.2 µg/mL) [45]. Conflicting results were obtained for alterations in sperm motility induced by 
metal-based NPs, a parameter used to evaluate sperm quality. A complete loss of bovine spermatozoa 
motility was reported after exposure to 2.5 mg/mL of europium oxide NPs (Eu2O3-NPs) [44], while a 
22% loss of motility was detected after treatment with 0.5–50 µM of Au-NPs [48,65]. The latter  
metal-based NPs also caused a reduction of motility in human fresh semen mixed with 500 µL of  
Au-NPs and the results of this study showed the ability of NPs to penetrate the heads and tails of 
spermatozoa inducing fragmentation of the sperm [46]. Finally, in the aforementioned study carried 
out by Terzuoli et al. [50], increasing concentrations of Ag-NPs significantly reduced human sperm 
motility. Conversely, motility and acrosome reactions of bovine sperm cells were not affected by 
exposure to 7.35 mM of magnetic iron oxide NPs (Fe3O4-NPs) coated with poly(vinyl alcohol) [43], or 
to 2.5 mg/mL of europium hydroxide NPs (EuOH3-NPs) conjugated with polyvinyl alcohol or 
polyvinyl piyrolidone [44]. Interestingly, these results suggest that the toxic potential of NPs may be 
altered by modifying NP surface functionalization. 
The detrimental effects of NPs on the maturation process of male germ cells have also been 
confirmed by numerous in vivo studies. An increase in the testicular apoptotic index and the frequency 
of round spermatidis with two or more nuclei were observed in CBAB6F1 mice treated via oral gavage 
with increasing (0–1000 mg/kg) concentrations of TiO2-NPs [55]. Similar findings (clear reduction in 
sperm density and motility) were obtained by Guo et al. [52] in ICR mice intraperitoneally injected 
with 500 mg/kg of TiO2-NPs. The intravenous administration to Wistar rats of 5 or 10 mg/kg of  
Ag-NPs, with different diameters, determined a decrease in epididymal sperm count and an increase in 
DNA damage in germ cells [56]. In this study, the most severe adverse effects were caused by the 
smaller particles (20 nm vs. 200 nm), suggesting a relevant role of diameter in inducing greater 
biological reactivity. This finding should be given careful consideration as it may be linked to the 
different interaction between the NP surface and biological substances present in biological fluids. In 
fact, NPs may change their physico-chemical characteristics when transferred to body fluids. This may 
be due to protein corona formed on the NP surface which facilitates the uptake of NPs into cells and 
cell inner structures, consequently inducing greater toxicity of particles in the nanometer size. 
Interestingly, the in utero exposure of male offspring in pregnant BALB/c mice treated with  
50–300 mg/kg of dimercaptosuccinic acid-coated Fe3O4-NPs also induced a significant reduction  
in spermatogonia, spermatocytes, spermatids and mature sperm [54]. However, in this study, 
histological examinations were conducted only on placental tissue and fetus liver, and even if the 
Fe3O4-NPs were passed via blood-placenta barrier, it is not clear whether the aforementioned findings 
were due the direct action of NPs on testes or to an accumulation in the placenta tissue. On the 
contrary, the administration to ICR mice of 45 and 225 mg/kg of mPEG@Au-NPs and of 45 mg/kg of 
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PEG-NH2@Au-NPs failed to result in abnormalities in the sperm collected from the cauda epididymis 
of the animals [39]. 
Regarding daily sperm production (DSP) and other sperm functional features such as motility and 
density, adverse effects were reported after both fetal and adulthood exposure to TiO2-NPs and  
CB-NPs. Takeda et al. [35] observed a decrease in DSP and epidydimal sperm motility in Slc:ICR 
mice prenatally exposed to TiO2-NPs and the exposure, via inhalation or intratracheal administration, 
of pregnant C57BL/6J mice to 42 mg/m3 of nanosized TiO2 or to 67 μg/animal of CB-NPs caused a 
reduction of DSP in male F1 offspring and lowered sperm production in the F2 offspring, whose 
fathers were prenatally exposed to CB-NPs [58]. DSP was significantly reduced also in 5 week-old and 
10–15 week-old male ICR mice after fetal exposure to 0.2 mg of CB-NPs [38], whereas adult mice 
subchronically exposed to 0.1 mg of CB-NPs showed a significant reduction in DSP [36]. However, 
other in vivo studies that evaluated alterations in spermatogenesis and sperm quality, using MWCNTs 
and other carbon-based NPs, failed to confirm the abovementioned findings. In fact, no alterations in 
the total sperm concentration, motility, percentage of abnormal semen and loss of acrosome integrity 
were detected in the study conducted by Bai et al. [37]. Likewise, Tang et al. [57], when evaluating  
the long term effects of short MWCNTs and polyethylene glycol functionalized s-MWCNTs  
(PEG-s-MWCNTs) in Kunming mice intravenously treated with a single dose of 100 μg/kg  
body weight, failed to observe sperm cell toxicity or changes in sperm morphologyFurthermore, in 
healthy and streptozotocin-induced diabetic male Wistar rats that were administered C60 fullerene 
(C60HyFn) at the dose of 4 μg/kg via the oral route, these NPs not only failed to cause significant toxic 
effects in testicular tissues, but actually increased both sperm motility and epididymal sperm 
concentration and decreased the abnormal sperm rate, indicating an important anti-oxidant activity [53]. 
It is worth noting that the lack of effects on the sperm functional features was observed mainly using 
functionalized and highly pure MWCNTs. Therefore, it can be assumed that the chemical composition 
and the functionalization of this type of NP play a key role in defining their toxicological profile. For 
instance, covalent modification of MWCNTs by linking PEG chains to the outside surface of 
MWCNTs has many advantages because it increases solubility, prolongs circulation half-life in vivo 
and reduces immunogenicity [57]. Another issue involving the capacity of NPs to interfere with the 
male reproductive system concerns the disruption of normal levels of sex hormones, particularly 
testosterone (see Table 2 and Figure 2). In fact, the results of two in vitro and ex vivo studies 
demonstrated that DE-NPs and CB-NPs are able to affect testosterone production in Leydig cells. In 
the study carried out by Komatsu et al. [30], after 48 h incubation, exposure of the TM3 Leydig cell 
line to 0–1000 µg/mL of DE-NPs and CB-NPs induced gene expression of the steroidogenic acute 
regulatory protein (StAR) which is an important molecule in the process of testosterone synthesis, 
involved as a carrier in cholesterol transfer from the outer to the inner mithocondrial membrane [66]. 
Moreover, the evaluation of testosterone production in interstitial testicular cells, dissected from male 
C57BL/Jcl mice exposed to 152.01 µg/m3 of NRDE-NPs, showed that this parameter significantly 
increased both with and without human chorionic gonadotropin stimulus [59].  
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Figure 2. Effects on pituitary-ovary and pituitary-testis axes caused by exposure to 
different types of NPs.  
 
Effects on pituitary-ovary axis: Au-NPs induced a greater output of estradiol from ovarian granulosa cells 
after 1–5 h of treatment, while they decreased the estradiol level after 24 h. TiO2-NP induced changes in 
hormone levels and ovarian injury in mice may be related to alterations in ovarian gene expression, e.g., 
Akr1c18, StAr, Cyp17a1, and Lgmn genes were up-regulated. Moreover, TiO2-NPs increased serum levels 
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of estradiol while they decreased those of progesterone, FSH, LH and testosterone in female mice; NRDE-NP 
exposure led to an increase in LH and estradiol and a reduction in progesterone levels in rats. mRNA 
expression of the cytochrome P450scc, the 3β-hydroxysteroid dehydrogenase, and the LH receptor were 
significantly reduced, while that of estradiol-17β was increased by NR-DE exposure, suggesting an 
impairment in luteal function. NRDE-NP alteration in progesterone secretion was due to the suppression of 
the steroid enzyme activity and the suppression of the production of LH receptors in corpora lutea;  
Effects on pituitary-testis axis: Au-NPs induced elevated testosterone levels that directly affected the 
testicular hormone production, since no alterations in LH and FSH plasma values were observed; NRDE-NPs 
increased the biosynthesis of testicular testosterone. This could be attributed to an increase in the mRNA 
expression of StAR and cytochrome P450 side-chain cleavage in Leydig cells. Increased levels of serum and 
testicular testosterone were related to an enhanced expression of genes involved in testicular cholesterol 
synthesis, such as HMG-CoA, LDL-R, SR-B1, PBR, P450scc, P450 17α, and 17β-HSD induced by NRDE-NPs. 
Increased testosterone production was due to the impaired balance between androgen-metabolizing- and 
testosterone biosynthetic-enzymes and not to an LH stimulation, as demonstrated by the absence of 
alterations in the LH and FSH levels; CB-NPs can affect testosterone production through the induction of 
StAR gene expression. 
Alterations in testosterone levels leading to impaired male reproductive function have also been 
investigated in numerous in vivo studies. Li et al. [33] observed that, in Fischer 344 rats, inhalation 
exposure to low (15.4 ± 1.0 µg/m3) and medium (36.4 ± 1.2 µg/m3) concentrations of NRDE-NPs 
significantly increased plasma and testicular testosterone, whereas this did not occur with exposure to 
a high concentration (168.8 ± 2.7 µg/m3), thereby clearly indicating an inverted-U dose-response. 
However, this phenomenon should be carefully evaluated since it may be due to agglomeration of NPs 
at the highest dose that reduces the activity of the nanoform. Plasma luteinizing hormone (LH) and 
follicle stimulating hormone (FSH) concentrations did not change significantly, while increased 
concentrations of the plasma and testicular immunoreactive (ir-) inhibin, a protein complex which 
inhibits FSH synthesis and secretion were observed in exposed groups. These findings suggest that the 
increased levels of testosterone were not related to LH stimulation but were due to the disrupted 
balance between androgen-metabolizing- and testosterone biosynthetic-enzymes. When attempting to 
clarify the mechanism responsible for the rise in testosterone levels, the same research group [60] 
confirmed results obtained by Komatsu et al. [30], thus proving that increased testosterone 
biosynthesis could be attributed to an increase in the mRNA expression of StAR and cytochrome P450 
side-chain cleavage (P450scc), an enzyme responsible for the conversion of transported cholesterol to 
pregnenolone in Leydig cells [67]. Similar findings and action mechanism were obtained in the same 
animal model exposed to high (149 ± 8 µg/m3) and low (38 ± 3 µg/m3) NRDE-NPs concentrations [61]. 
Furthermore, higher levels of testosterone were also observed in male C57BL/Jcl mice treated with 
152.01 µg/m3 of NRDE-NPs and the increase in this hormone was related to an enhanced expression of 
genes involved in testicular cholesterol synthesis, such as HMG-CoA, LDL-R, SR-B1, PBR, P450scc, 
P450 17α, and 17β-HSD [59]. Interestingly, in pregnant Fischer F344 rats, exposure to 148.86 µg/m3 
of NRDE-NPs caused changes in offspring hormone levels involving decreased FSH and testosterone 
and increased ir-inhibin concentrations that were quite different from those observed in adult  
animals [34]. The possibility of NPs affecting reproductive function in different ways depending on 
the period of exposure i.e., during adulthood or the fetal period, is also corroborated by the findings of 
Yoshida [36,38] who reported elevated testosterone levels in ICR adult mice treated with CB-NPs but 
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no significant increase in the offspring after in utero exposure. Elevated testosterone levels were also 
detected following the administration of PEG-NH2@Au-NP in ICR mice, while no alterations in LH 
and FSH plasma values were observed [39]. Taken together, these results suggested that modified-Au-NPs 
may act as endocrine disruptors that have a direct influence on testicular hormonal production, since 
pituitary LH and FSH levels remained unmodified. Moreover, NP surface chemistry would seem to 
play an important role in inducing hormonal alterations, in fact, unlike PEG-NH2@Au-NP, the 
mPEG@Au-NPs did not cause an increase in testosterone concentration. As confirmation of the 
importance of the functionalization of NPs in affecting sex hormone levels, no alterations in 
testosterone, LH and FSH plasma levels were observed in BALB/c mice, subacutely exposed to 
functionalized MWCNTs [37]. 
The aformentioned studies that investigated the adverse effects of NPs on male reproductive 
function used different types of NPs, cell lines, exposure routes and doses. Consequently, caution is 
needed when interpreting their findings, and reaching a definite conclusion poses a considerable 
challenge. Any evaluation of these results may take into account the fact that the exposure 
concentrations used in most of the studies were very high (up to 2.5 mg/mL and 1000 mg/kg for  
in vitro and in vivo studies respectively) and would probably be difficult to find in an environmental 
exposure context. Finally, it should be noted that the different toxic effects induced by NPs were 
strongly related to their physico-chemical properties which, in most of the studies we reviewed, were 
not adequately analyzed and defined. In fact, NP characterization often focuses only on the chemical 
composition and particle size (see Table 2) while, in our opinion it is extremely important to assess 
other relevant parameters such as surface area, reactivity and functionalization, charge, solubility, 
degree of agglomeration and number concentration. 
2.2. Effects of NPs on the Female Reproductive System 
In recent years, numerous in vitro and in vivo studies have evaluated the potential adverse effects of 
NP exposure on the female reproductive system. Study findings have demonstrated that several NPs 
can interfere with normal female reproductive function by inducing cytotoxic effects on ovarian 
structural cells, impairing oogenesis and follicle maturation, and altering normal sex hormone levels 
(see Table 3). 
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Table 3. Effects of N
Ps on the fem
ale reproductive system
. 
Type of 
study 
Type and physico-chemical properties 
of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
Results 
References 
Effects on ovarian cells 
In vitro 
A
natase TiO
2 -N
Ps (30 nm
) 
Treatm
ent w
ith increasing 
concentrations of TiO
2 -N
Ps  
(0–100 μg/m
L) for 24 h 
C
H
O
-K
1 
x 
Reduction of cell viability 
according to the increasing 
dose applied and the 
increasing RO
S concentration 
induced. 
[68] 
In vitro 
TiO
2 -N
Ps (anatase-80%
 rutile-20%
 w
ith 
organic coating, ~21 nm
; anatase-80%
 
rutile-20%
 doped w
ith di-iron trioxide, 
~21 nm
; anatase-80%
 rutile-20%
,  
~21 nm
; rutile 100%
 w
ith inorganic and 
organic coating, 14 nm
; anatase 100%
 
w
ith inorganic coating, 60 nm
; rutile 
100%
 w
ith inorganic and organic coating, 
20 nm
; rutile 100%
 w
ith inorganic and 
organic coating, 15 nm
; rutile 100%
 w
ith 
inorganic coating, 20–22 nm
) 
Exposure for 3 h to different 
concentrations of TiO
2 -N
Ps  
(800, 1950, 3000, 5000 μg/m
L) 
C
H
O
-W
B
L 
x 
N
one of the titanium
 dioxide 
particles tested induced any 
increase in chrom
osom
al 
aberration frequencies either 
in the absence or presence  
of U
V
. 
[69] 
In vitro 
TiO
2 -N
Ps (rutile-79%
 anatase-21%
, 
particle size: 140 ± 44 nm
, surface area: 
38.5 m
2/g) 
C
ytogenetic evaluations w
ere 
conducted exposing cells to 750, 
1250, and 2500 µg/m
L for the 4 h 
non-activated test condition, to 62.5, 
125, and 250 µg/m
L, for the 4 h  
activated test condition, and to 25, 
50, and 100 µg/m
L for the 20 h  
non-activated test condition. 
C
H
O
 
x 
G
enotoxicity tests 
dem
onstrated that TiO
2 -N
Ps 
w
ere negative in in vitro 
m
am
m
alian chrom
osom
e 
aberration test w
ith Chinese 
ham
ster ovary cells;  
TiO
2 -N
Ps did not induce 
structural or num
erical 
chrom
osom
e aberrations in 
this study. 
[70] 
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Table 3. Cont. 
Type of 
study 
Type and physico-chemical properties 
of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
Results 
References 
Effects on ovarian cells 
In vitro 
A
natase TiO
2 -N
Ps (10–20, 50–60 nm
) 
and rutile TiO
2 -N
Ps (50–60 nm
) 
Treatm
ent w
ith increasing 
concentrations of TiO
2 -N
Ps  
(25–325 μg/m
L) for 24 h 
C
H
O
 
x 
R
esults show
ed toxic effects 
on C
H
O
 cells w
ith a toxic 
order as 10–20 nm
 anatase  
> 50–60 nm
 anatase  
> 50–60 nm
 rutile, w
hich w
as 
consistent w
ith that of 8-O
H
dG
 
generation and D
N
A
 strand 
breaking activities. 
[71] 
In vitro 
TiO
2 -N
Ps (shape: com
plex; average 
particle sizes: 20 ± 7 nm
; specific surface 
area: 142 m
2/g) and A
l2 O
3 -N
Ps (shape: 
spherical; average particle sizes:  
28 ± 19 nm
; specific surface area:  
39 m
2/g) 
Treatm
ent w
ith increasing 
concentrations of N
Ps (0.5, 1, 5, 10, 
25, 50 and 100 μg/m
L) for 24 h 
C
H
O
-K
1 
x 
Results show
ed a dose-related 
cytotoxic effect m
anifested 
after 24 h by changes in 
lysosom
al and m
itochondrial 
dehydrogenase activity;  
The cytotoxic effects induced 
by A
l2 O
3 -N
Ps w
ere w
eaker 
than those exerted by  
TiO
2 -N
Ps, and began at 
higher concentrations;  
G
enotoxic effects w
ere 
show
n by M
N
 frequencies 
w
hich significantly increased 
at 0
. 5 and 1 μg/m
L TiO
2  and 
0.5–10 μg/m
L A
l2 O
3 ;  
SCE frequencies w
ere higher 
for cells treated w
ith  
1–5 μg/m
L TiO
2 -N
Ps. 
[72] 
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Table 3. Cont. 
Type o f study 
Type and phys ic o-chemical properties 
of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
Results 
References 
Effects on ovarian cells 
In vitro 
SiC
N
W
 (diam
eter of 80 nm
; chem
ical 
com
position: Si to C
 ratio close to 
1:1) 
Exposure to different concentrations 
(0.5, 1.0, 5.0 and 10.0 μg/m
L) of 
SiC
N
W
s for 1, 3, and 5 days 
C
H
O
 
x 
C
H
O
 cells in contact w
ith 
SiC
N
W
s had significantly 
low
er reproduction rates and 
genom
ic instability;  
A
ctivation of the M
A
PK
s 
cellular signaling pathw
ay 
and over-expression of 
C
O
X
-2 w
ere the m
ain 
toxicity m
echanism
s;  
M
N
 ratio rose sharply w
ith 
increasing SiC
N
W
s 
concentrations and very 
significant differences w
ere 
found after exposure to  
5 and 10 μg/m
L SiC
N
W
s. 
[73] 
In vitro 
C
alcium
 phosphate-N
Ps (20–30 nm
, 
less than 10%
 particles w
ere greater 
than 100 nm
) 
C
ells w
ere divided into different 
groups of exposure: control (treated 
w
ith 4-androstene-3,17-dione), 
group II (treated w
ith 10 µM
 of 
C
alcium
 phosphate-N
Ps and  
4-androstene-3, 17-dione) and group 
III (treated w
ith 100 µM
 of C
alcium
 
phosphate-N
Ps and 4-androstene-3, 
17-dione) 
G
ranulosa cells 
collected from
 
infertilite w
om
en 
x 
Increased percentage of cells 
in S phase;  
Increased apoptotic rate after 
the cells w
ere treated w
ith 
100 µM
 of calcium
 
phosphate-N
Ps for 48 h. 
[74] 
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Table 3. Cont. 
Type of 
study 
Type and physico-chemical properties 
of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
Results 
References 
Effects on ovarian cells 
In vitro 
M
W
C
N
Ts (diam
eter ~10 nm
) 
In order to observe if the M
W
N
T 
sheets have any toxic effect on cells, 
C
H
O
 cells w
ere allow
ed to grow
 on 
the substrates until about 90%
 
confluence 
C
H
O
 
x 
N
o toxicity w
as observed;  
The cells grew
 w
ell and 
aligned and only a few
 cells 
elongated along the axis of 
the M
W
C
N
T bundles. 
[75] 
In vitro 
A
natase TiO
2 -N
Ps (<25 nm
) 
C
ells w
ere m
aintained under 
exponential grow
th conditions and 
w
ere continuously exposed for 1, 2, 
or 60 days to either 0, 10, 20, 40, 100 
and 200 µg/m
L of N
Ps 
C
H
O
-K
1 
x 
C
ell viability or proliferative 
ability w
as negatively 
affected by acute exposure 
at concentrations of  
100 µg/m
L and 200 µg/m
L 
as m
easured by cell counts 
and colony form
ation;  
N
o genotoxic effects. 
[76] 
In vitro 
A
natase TiO
2 -N
Ps (<25 nm
) 
Treatm
ent w
ith different 
concentrations of N
Ps (0, 25, 50, 100 
and 200 µg/m
L). C
ells w
ere 
incubated for 24 h and 48 h. 
C
H
O
-K
1 
x 
B
ased on the trypan blue 
assay, viability decreased at 
the tw
o higher 
concentrations;  
The decrease in cell viability 
using the M
TT assay w
as 
only observed at the highest 
concentration and at 48 h 
incubation. 
[77] 
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Table 3. Cont. 
Type of 
study 
Type and physico-chemical 
properties of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
Results 
References 
Effects on ovarian cells 
In vitro 
N
aked m
esoporous silica N
Ps  
(10 nm
 and 50 nm
); carboxyl or 
am
ine m
odified m
esoporous silica 
N
Ps;  
carboxyl-m
odified  
polystyrene-N
Ps (30 nm
); 
polystyrene-N
Ps functionalized w
ith 
am
ine groups (50 nm
) 
Exposure of N
IH
-O
V
C
A
R
3 for 48 h to 30 
and 75 µg/m
L of naked m
esoporous silica 
N
Ps (10 nm
); exposure of N
IH
-O
V
C
A
R
3 
and SK
O
V
3 cells for 1 and 24 h to  
20 µg/m
L of naked m
esoporous silica 
N
Ps (50 nm
) and of carboxyl or am
ine 
m
odified m
esoporous silica N
Ps; 
exposure of N
IH
-O
V
C
A
R
3 and SK
O
V
3 
cells for 24 and 48 h to  
75 µg/m
L of carboxyl-m
odified 
polystyrene-N
Ps and  
polystyrene-N
Ps functionalized w
ith 
am
ine groups 
O
varian N
IH
-
O
V
C
A
R
3 epithelial 
cancer cells;  
SK
O
V
3 cancer cells 
x 
N
o altered cell m
orphology, 
m
etabolism
 or cell loss w
as 
detected in N
IH
-O
V
C
A
R
3 
and SK
O
V
3 cells treated 
w
ith naked m
esoporous 
silica N
Ps or carboxyl or 
am
ine m
odified m
esoporous 
silica N
Ps;  
Evident internalization of 
the N
Ps could be observed.  
C
arboxyl-m
odified 
polystyrene-N
Ps w
ere not 
toxic for N
IH
-O
V
C
A
R
3 and 
SK
O
V
3 cells;  
Polystyrene N
Ps 
functionalized w
ith am
ine 
groups show
ed significant 
cytotoxic effects. 
[78] 
In vitro 
M
W
C
N
Ts (average diam
eter:  
67 nm
;  
surface area: 26 m
2/g; carbon purity: 
99.79 w
t%
) 
Exposure for 24 h to 1, 10 and  
100 µg/m
L of N
Ps 
M
A
R
C
O
-transfected 
C
H
O
-K
1 cells 
x 
M
W
C
N
Ts are highly 
cytotoxic;  
The toxicity of M
W
C
N
Ts 
m
ay be due to the 
incom
plete inclusion of 
these N
Ps by the m
em
brane 
structure. 
[79] 
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Table 3. Cont. 
Type of 
study 
Type and physico-chemical properties 
of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
Results 
References 
Effects on oogenesis and follicle maturation 
In vitro 
TiO
2 -N
Ps (25 nm
) 
Exposure to increasing 
concentrations (12.5–50 μg/m
L) of 
TiO
2 -N
Ps 
R
at preantral follicles 
x 
TiO
2 -N
Ps inhibited rat 
follicle developm
ent and 
oocyte m
aturation;  
Survival rate of follicles, 
form
ation rate of antral 
follicles and release rate of 
cum
ulus-ocyte cell 
com
plexes w
ere  
dose-dependently decreased. 
[80] 
In vitro 
C
dSe-core-Q
D
s and ZnS-coated  
C
dSe Q
D
s (3.5 nm
) 
Exposure for 24 h to 0, 125, 250 and 
500 nM
 of C
dSe-core-Q
D
s and to 
500 nM
 of ZnS-coated C
dSe Q
D
s 
C
um
ulus-oocyte 
com
plexes collected 
from
 fem
ale  
IC
R
 m
ice 
x 
CdSe-core-Q
D
s, but not 
ZnS-coated C
dSe Q
D
s, 
induced dose-dependent 
decrease in oocyte 
m
aturation rate, reduced 
fertilization, im
pairm
ent of 
cell proliferation and  
dose-dependent enhanced 
blastocyst apoptotic rate. 
[81] 
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Table 3. Cont. 
Type of 
study 
Type and physico-chemical properties 
of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
Results 
References 
Effects on oogenesis and follicle maturation 
In vitro 
Lysine coated C
dSe/C
dS/ZnS Q
D
s  
(~20 nm
) 
Exposure for 4, 8, 16 and 24 h to 
5.78 nm
ol/L and 29.8 nm
ol/L of 
Lysine coated C
dSe/C
dS/ZnS Q
D
s 
Im
m
ature oocytes of 
28 days  
K
unm
ing m
ice 
x 
O
ocyte m
aturation process 
has high susceptibility for 
disturbances induced by 
C
dSe/C
dS/ZnS Q
D
s;  
C
dSe/C
dS/ZnS Q
D
s 
interfere w
ith the process of 
oocyte m
aturation 
disfunctioning the cum
ulus 
cells or disturbing the signal 
interaction betw
een germ
 
cell and som
atic cell. 
[82] 
In vitro 
C
dSe/C
dS/ZnS Q
D
s 
Exposure for 4, 8 and 20 h to  
28.9 nm
ol/L of Q
D
s 
Im
m
ature oocytes 
w
ere collected from
 
K
unm
ing m
ice 
x 
Q
D
s enter cum
ulus cells and 
accum
ulate w
ith co-culture 
tim
e; A
fter being treated for 
20 h and being rejected by 
oocytes, Q
D
s decrease the 
ratio of oocyte in vitro 
m
aturation dram
atically. 
[83] 
In vitro 
C
dTe/ZnTe Q
D
-Transferrin bioconjugates 
Preantral follicles w
ere treated w
ith 
escalating concentrations of (0.0289, 
0.289, 2.89 and 28.9 nm
ol/L) 
C
dTe/ZnTe Q
D
-Transferrin 
bioconjugates for 8 days 
Pre antral follicles 
w
ere collected from
 
fem
ale  
K
unm
ing m
ice 
x 
D
ose-dependent up-take of 
Q
D
s-Tf by theca and 
granulosa cells;  
A
 significant decrease in the 
rate of antrum
 cavity 
form
ation and the ratio of 
oocytes w
ith first polar body 
w
as observed. 
[84] 
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Table 3. Cont. 
Type of 
study 
Type and physico-chemical properties 
of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
Results 
References 
Effects on oogenesis and follicle maturation 
In vivo 
TiO
2 -N
Ps (anatase; N
Ps w
ere found to 
aggregate in culture m
edium
 and 
consequently the m
ean sizes w
ere  
240–280 nm
 (0.1 m
g/L) and 259–360 nm
  
(1.0 m
g/L) 
R
eproductively active fish w
ere 
exposed for 13 w
eeks to 0.1 and  
1.0 m
g/L 
Zebrafish Danio rerio 
x 
Chronic exposure to 0.1 m
g/L 
of TiO
2 -N
Ps can significantly 
im
pair zebrafish reproduction;  
Reduced expression of genes 
coding for grow
th factors 
im
plicated as paracrine 
stim
uli in the oocyte 
m
aturation. 
[85] 
In vivo 
TiO
2 -N
Ps (anatase, average particle size: 
6 nm
, surface area: 174.8 m
2/g) 
TiO
2 -N
Ps suspensions at different  
concentrations (2.5, 5, and 10 m
g/kg 
of body w
eight) w
ere adm
inistered 
to m
ice by intragastric 
adm
inistration for  
90 consecutive days.  
C
D
-1 (IC
R
) fem
ale 
m
ice 
x 
TiO
2 -N
Ps can accum
ulate in 
the ovary and result in 
ovarian dam
age, causing an 
im
balance of m
ineral 
elem
ent distribution, 
decreased fertility or 
pregnancy rate and oxidative 
stress in m
ice. 
[86] 
In vivo 
A
g-N
Ps (3 and 35 nm
) 
Exposure to 10 µg/L of A
g-N
Ps for 
35 days 
Sheepshead m
innow
s 
(Cyprinodon 
Variegatus) 
x 
G
ene expression analysis 
revealed a dram
atic 
transcriptional response 
indicating that exposure to 
these N
Ps has the potential 
to cause reproductive 
dysfunction;  
A
bsence of ovary 
m
orphological and 
developm
ental alterations. 
[87] 
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Table 3. Cont. 
Type of 
study 
Type and physico-chemical properties 
of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
Results 
References 
Effects on oogenesis and follicle maturation 
In vivo 
TiO
2 -N
Ps (anatase-75%
 rutile-25%
, 
average prim
ary particle size: 21 nm
, 
specific surface area: 50 ± 15 m
2/g) 
R
eproductively active fish w
ere 
exposed for 14 days to 0.1 and  
1.0 m
g/L 
Zebrafish Danio rerio 
x 
Fem
ale gonad show
ed a 
norm
al spread of oocyte 
developm
ent stages;  
The highest TiO
2 -N
Ps dose 
caused a m
arkedly low
er 
production of eggs and 
viable em
bryos. 
[88] 
Disruption of normal levels of sex hormones 
In vitro 
A
u-N
Ps (10 nm
) 
Exposure for 1,3,5 and 24 h to  
2.85 × 10
10 N
Ps/m
L 
R
at granulosa cells 
x 
A
u-N
Ps induced a greater 
output of estradiol at 1–5 h 
of treatm
ent;  
A
 significant decrease in 
estradiol w
as observed at  
24 h. 
[89] 
In vitro 
C
alcium
 phosphate-N
Ps (20–30 nm
, less 
than 10%
 particles w
ere greater than  
100 nm
) 
C
ells w
ere divided into different 
groups of exposure: control (treated 
w
ith 4-androstene-3,17-dione), 
group II (treated w
ith 10 µM
 of 
C
alcium
 phosphate-N
Ps and  
4-androstene-3, 17-dione) and group 
III (treated w
ith 100 µM
 of C
alcium
 
phosphate-N
Ps and 4-androstene-3, 
17-dione) for 48 h 
G
ranulosa cells 
collected from
 
infertile w
om
en 
x 
Treatm
ent w
ith calcium
 
phosphate-N
Ps did not 
significantly change either 
the progesterone or estradiol 
levels in culture fluid;  
N
o changes in the 
expression levels of m
R
N
A
s 
encoding P450scc, 
P450arom
 and StA
R
. 
[74] 
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Table 3. Cont. 
Type of 
study 
Type and physico-chemical 
properties of NPs 
Experimental protocol 
Cell 
line/laboratory 
animals 
Results 
References 
Disruption of normal levels of sex hormones 
In vitro 
C
dTe/ZnTe Q
D
-Transferrin 
bioconjugates 
Preantral follicles w
ere treated w
ith 
escalating concentrations of  
(0.0289, 0.289, 2.89 and 28.9 nm
ol/L) 
C
dTe/ZnTe Q
D
-Transferrin 
bioconjugates for 8 days 
Pre antral follicles 
w
ere collected 
from
 fem
ale 
K
unm
ing m
ice 
x 
Increase in 17 β-estradiol secretion, at the  
4th-8th day post-treatm
ent, at the highest  
Q
D
-Tf concentration; 
x 
17 β-estradiol secretion decreased com
pared 
to controls at low
er Q
D
-Tf concentrations. 
[84] 
In vivo 
TiO
2 -N
Ps (anatase, average 
particle size: 6 nm
, surface 
area: 174.8 m
2/g) 
TiO
2 -N
P suspensions at different  
concentrations (2.5, 5, and 10 m
g/kg 
of body w
eight) w
ere adm
inistered 
to m
ice by intragastric adm
inistration 
for 90 consecutive days.  
C
D
-1 (IC
R
) 
fem
ale m
ice 
x 
H
igher serum
 levels of estradiol;  
Low
er serum
 levels of progesterone, FSH
, LH
 
and testosterone. 
[86] 
In vivo 
N
R
D
E-N
Ps (22–27 nm
; 
particle com
position show
ed 
a higher percentage of 
organic carbon than 
elem
ental carbon) 
Inhalation exposure, for 5 h daily 
from
 day 1 to 19 of gestation, to 
148.86 µg/m
3 
Pregnant Fischer 
344 rats 
x 
Increase in LH
 levels;  
D
ecrease in progesterone levels;  
N
o significant differences w
ere observed in 
FSH
, prolactin, ir-inhibin and testosterone 
levels. 
[90] 
In vivo 
ZnO
-N
Ps (20–30 nm
) 
O
ral adm
inistration of  
333.33 m
g/kg of ZnO
-N
Ps 
W
istar rats 
x 
The sexual horm
one level (FSH
, LH
 and 
estradiol) show
ed no significant difference 
betw
een control and treatm
ent group. 
[91] 
8-O
H
dG
, 8-hydroxy-2-deoxyguanosine; A
g-N
Ps, Silver N
anoparticles; A
l2 O
3 -N
Ps, A
lum
inium
 oxide N
anoparticles; A
u-N
Ps, G
old N
anoparticles; C
dS-Q
D
s, C
adm
ium
 
Sulfide Q
uantum
 D
ots; C
dSe-Q
D
s, C
adm
ium
 Selenium
 core Q
uantum
 D
ots; C
dTe/ZnTe Q
D
, C
adm
ium
 Tellurium
/Zinc Tellurium
 Q
uantum
 D
ots; C
O
X
-2, 
C
yclooxygenase-2; FSH
, Follicle Stim
ulating H
orm
one; LH
, Luteinizing H
orm
one; M
A
PK
s, M
itogen-A
ctivated Protein K
inases; M
N
, M
icro N
uclei; M
A
R
C
O
, 
M
acrophage R
eceptor w
ith C
ollagenous structure; M
W
C
N
Ts, M
ulti W
alled C
arbon N
anotubes; M
TT, 3-(4,5-dim
ethyl-2-thiazol)-2,5-diphenyl-2H
-tetrazolium
 brom
ide; 
N
R
D
E-N
Ps, N
anoparticle-R
ich D
iesel Exhaust N
anoparticles; P450arom
, A
rom
atase P450; P450scc, C
ytochrom
e P450 side-chain cleavage; R
O
S, R
eactive O
xygen 
Species; SC
E, Sister C
hrom
atid Exchanges; SiC
N
W
s, Silicon C
arbide N
anow
ires; StA
R
, Steroidogenic A
cute R
egulatory protein; TiO
2 , Titanium
 D
ioxide; TiO
2 -N
Ps, 
Titanium
 D
ioxide nanoparticles; U
V
, U
ltra V
iolet; ZnO
-N
Ps, Zinc O
xide N
anoparticles; ZnS, Zinc Sulfide; ZnS-Q
D
s, Zinc Sulfide Q
uantum
 D
ots. 
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Different types of NPs, in particular TiO2-NPs, carbon-based NPs and silica NPs, were studied in 
order to define their cytotoxic potential on Chinese hamster ovary cells (CHO), epithelial-like ovarian 
constituent cells. With regard to metal-based NPs, data currently available have shown the ability of 
TiO2-NPs to be internalised by CHO-K1 and to induce a dose-dependent decrease in cell viability 
following both acute [68,71,72] and subacute exposure [76,77]. Anatase TiO2-NPs reduced cell 
viability in relation to the increasing dose applied (0–100 μg/mL) and the increasing ROS 
concentrations induced [68]. Similarly, anatase and rutile TiO2 NPs caused a cytotoxic effect in CHO 
cells treated with concentrations ranging from 25 to 325 μg/mL [71]. The results of this study showed 
that particle size and crystal phase composition can significantly affect the cytotoxic behaviour of NPs 
since 10–20 nm anatase yielded the highest level of cytotoxicity followed by 50–60 nm anatase and  
50–60 nm rutile. Comparable results were obtained by Di Virgilio et al. [72] on treating CHO-K1 cells 
with 0–100 μg/mL of non-characterized (in terms of crystal phase composition) TiO2-NPs. Moreover, 
cell viability was negatively affected by acute and subacute exposure to concentrations of >50 μg/mL 
of anatase TiO2-NPs [76,77]. The most significant toxic effects were observed following treatment 
with particularly high doses of TiO2-NPs (100 and 200 μg/mL). However, these results should be 
interpreted with caution since the applied doses may not be representative of exposure levels in the 
general population or in occupationally exposed subjects. Aluminium oxide NPs (Al2O3-NPs), another 
type of metal-based NP, were able to penetrate the cytoplasm of CHO-K1 cells treated with  
0–100 μg/mL [72], inducing dose-dependent cytotoxic damage. However, this was not so severe as the 
damage caused by TiO2-NPs and began at higher concentrations suggesting that the chemical 
composition of NPs is also important in causing toxic effects.  
In a study on carbon-based NPs that examined the effects on CHO cell viability, of silicon carbide 
nanowires (SiCNWs) obtained from the reaction of MWCNTs with silicon monoxide, Jiang et al. [73] 
reported an important decrease in the reproduction rate. The main mechanism leading to SiCNW 
cellular toxicity was identified in the induction of the mitogen-activated protein kinase cellular 
signaling pathway and in the over expression of cyclossigenase-2. In the same cell line, transfected 
with the macrophage receptor with collagenous structure (MARCO), treatment with increasing 
concentrations (1–100 μg/mL) of MWCNTs caused significant cytotoxicity that was probably related 
to the incomplete inclusion of NPs by the cell membrane [79]. Furthermore, treatment of female 
granulosa cells, collected from infertile women, with calcium phosphate-NPs (10 and 100 μM), caused 
an accumulation in the S phase of the cell cycle with an increased apoptotic rate [74]. With regard to 
cytotoxicity in ovarian cells it is interesting to note that metal-based and carbon-based NPs may 
produce an effect through different molecular mechanisms of action such as the induction of oxidative 
stress and the activation of MAPKs cellular signaling/over-expression of COX-2, respectively. 
In contrast, when CHO cells were seeded on an aligned MWCNT substrate, no toxicity was 
observed: the cells grew well and were aligned, and only a few cells elongated along the axis of the 
MWCNT bundles [75]. Studies have also demonstrated good biocompatibility of mesoporous silica 
NPs with human ovary cells. In fact, when naked mesoporous silica NPs were applied to ovarian  
NIH-OVCAR3 epithelial cancer cells (30, 75 µg/mL), no altered cell morphology, metabolism or cell 
loss was reported, although there was evidence of internalization of the NPs [78]. Comparable results 
were obtained in NIH-OVCAR3 and SKOV3 cancer cells treated with 20 µg/mL of greater or 
differently functionalized (carboxyl or amine modified) mesoporous silica NPs. In the same study, 
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carboxyl-modified polystyrene-NPs were not toxic for NIH-OVCAR3 and SKOV3 cells at a 
concentration of 75 µg/mL, while polystyrene NPs functionalized with amine groups showed 
significant cytotoxic effects [78]. The absence of toxic effects of silica NPs in the latter study, 
compared to those previously analyzed, may be related to a number of factors, including the different 
type of NPs used (mesoporous silica NPs vs metal and carbon-based NPs), cell models adopted  
(NIH-OVCAR3 and SKOV3 vs CHO) and lower exposure concentrations, whereas the different 
functionalization of polystyrene-NPs seems to play a decisive role in the induction of cytotoxic effects.  
Conflicting results were obtained for the genotoxic effects of metal-based NPs on the CHO cell 
line. In fact, at doses < 5000 µg/mL, anatase and rutile TiO2-NPs failed to produce any increase in 
chromosomal aberration frequencies in CHO-WBL cells, either in the absence or presence of UV [69]. 
Similarly, no structural or numerical chromosome aberrations were observed in CHO cells exposed to 
several doses (25–2500 µg/mL) of rutile TiO2-NPs [70] and no genotoxic effects were detected in  
the CHO-K1 cell line treated with increasing concentrations (0, 10, 20, or 40 µg/mL) of anatase  
TiO2-NPs [76]. Conversely, studies carried out by Zhu et al. [71] and Di Virgilio et al. [72] reported  
an increased frequency of sister chromatid exchange, micronuclei and DNA strand breaks. Moreover, 
Al2O3-NPs induced a dose-dependent response of micronuclei frequency in the whole dose-range 
studied [72]. Comparable results were obtained with SiCNW exposure [73]. The different experimental 
design as well as the chemical composition of the NPs and the crystal form of the TiO2-NPs were 
probably responsible for most of the inconsistencies observed. In particular, it is worth noting that  
3 h [69] and 4 h [70] exposure periods may not be long enough to detect genotoxic effects, indicating 
that the response is also dependent on the exposure time. 
Oocyte viability and maturation are extremely sensitive to microenvironment changes and 
extracellular chemical compounds [81]. Consequently, several in vitro studies have been carried out to 
assess the potential adverse effects of NPs on female germ cells (see Table 3). The findings of these 
studies, which indicated an alteration in oocyte maturation and fertilization and their subsequent 
embryonic development, point to the role of TiO2-NPs and Quantum Dots (QDs) as endocrine 
disruptors. In fact, Hou et al. [80] demonstrated that TiO2-NPs (12.5–50 μg/mL) inhibited rat follicle 
development and oocyte maturation, with a dose-dependent reduction in the survival rate of follicles, 
formation rate of antral follicles and release rate of cumulus-oocyte cell complexes. Similar results, 
(dose-dependent decrease in oocyte maturation rate, reduced fertilization, impairment of cell 
proliferation and dose-dependent enhanced blastocyst apoptotic rate) were observed on oocytes isolated 
from female ICR mice exposed to 0–500 nM of cadmium selenium core QDs (CdSe-core-QDs). 
However, the coating of QDs with a zinc sulfide shell prevented the cytotoxic effects on oocytes, 
thereby suggesting that QD surface chemistry plays an important role [81]. The results of this study are 
particularly intriguing since they point out the importance of surface functionalization of QDs in 
altering their biological effects. In fact, the Authors suggested that the ZnS coating of CdSe QDs 
prevented cytotoxicity by blocking surface oxidation and the subsequent release of Cd2+ ions, 
mechanisms that are correlated with the induction of cell death by CdSe-core QDs. Therefore, it is 
plausible to assume that NPs may exert their toxic effects by dissolving to become a source/reservoir 
of toxic cations. The possible release of ions from metal-based NPs and QDs is an important topic that 
needs careful consideration when evaluating the potential toxic effects of these NPs. The same 
research group investigated the effects of CdTe/ZnTe QD-Transferrin (QD-Tf) bioconjugates on 
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follicle development and oocyte maturation in female Kunmimg mice. Their findings revealed a  
dose-dependent up-take of QDs-Tf by theca and granulosa cells and a significant decrease in the  
rate of antrum cavity formation and of the ratio of oocytes to first polar body [84]. These results 
suggested that the high uptake of QDs-Tf could potentially disturb oocytes to form antrum cavity and 
advance in maturation, as previously reported by Xu et al. [82] and Wang et al. [83] who, after treating 
Kunming mice immatured oocytes with CdSe/CdS/ZnS QDs, observed a significant reduction in the 
oocyte maturation process. The high uptake of QDs-Tf was probably due to the small hydrodynamic 
diameter and the bioconjugation of QDs that can facilitate penetration and increase impact on oocytes. 
Impairment of the female reproductive function, due to some metal-based NPs and QDs that modify 
oogenesis and follicle maturation, has also been observed in several in vivo studies (see Table 3). 
Wang et al. [85] reported that administration of TiO2-NPs to zebrafish Danio rerio at concentrations of 
0.1 and 1.0 mg/L, skewed the distribution of follicular developmental stages toward immature statuses 
and reduced the expression of gene coding for growth factors implicated as paracrine stimuli in oocyte 
maturation. Interestingly, when zebrafish Danio rerio were exposed to the same NP concentrations for 
a shorter period of time, female gonads showed a normal spread of oocyte development stages in all 
exposed groups [88]. However, the group treated with the highest TiO2-NPs dose (1.0 mg/L) yielded a 
much lower production of eggs and viable embryos. The differences in oocyte development stages 
observed in these studies could be due to the different exposure periods (13 weeks vs. 14 days). 
Accumulation of anatase TiO2-NPs in the ovary tissues of CD-1 (ICR) female mice, intragastrically 
treated with 10 mg/kg of these NPs, caused atresia of primary and secondary follicle development and 
led to increased Ca, Na, K, and Zn contents, and decreased Mg, Cu, and Fe contents [86]. Modification 
of the equilibrium of these elements in the ovaries might adversely affect their normal physiology and 
consequently lead to alterations in the female germ cell maturation process. Gene expression analysis 
in ovary tissues of adult sheepshead minnows (Cyprinodon Variegatus) exposed to 10 µg/L of  
Ag-NPs, revealed a dramatic transcriptional response indicating that exposure to these NPs can  
cause reproductive dysfunction in estuarine fish, even though the absence of ovary morphological and 
developmental alterations did not support this hypothesis [87].  
It has been demonstrated that a number of NPs are able to alter physiological sex hormone levels in 
the female as well as the male reproductive system (see Table 3 and Figure 2). In in vitro studies,  
Au-NPs and QDs were found to alter estrogenic hormonal levels. The exposure of rat ovarian 
granulosa cells to 2.85 × 1010 NPs/mL of metal-based NPs induced a greater output of estradiol after 
1–5 h of treatment, while a significant decrease was observed after 24 h. Initial estradiol accumulation 
could be ascribed to alterations induced by the internalized Au-NPs in the cleavage activity of 
cholesterol into pregnenolone, and in mitochondrial permeability, while the subsequent inhibition of 
estradiol production was probably due to impairment of the mitochondrial steroidogenic machinery [89]. 
The same mechanism of action has been proposed to explain the increase, at the 4th–8th day  
post-treatment, in 17 β-estradiol secretion into granulosa cells treated with the highest QD-Tf 
concentration. 17 β-estradiol secretion was less than in controls at lower QD-Tf concentrations [84]. 
Unlike previous studies, the production of progesterone and estradiol in the granulosa cells was not 
affected by treatment with calcium phosphate-NPs and no alterations were observed in the levels and 
expression of mRNA encoding P450scc, P450arom, and StAR [74]. These results did not agree with 
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the findings of Stelzer and Hutz [89] and Xu et al. [84] and it is possible that these disparities may be 
due to differences in dosage, chemicals, particle size, and cell model in the aforementioned studies. 
The issue concerning alterations in sex hormone levels caused by exposure to metal-based NPs and 
NRDE-NPs, has also been addressed by some in vivo studies which have, however, provided 
conflicting results. In fact, serum levels of estradiol significantly increased, while progesterone, FSH, 
LH and testosterone levels diminished in female CD-1 (ICR) mice sub-chronically treated with  
TiO2-NPs [86]. Nevertheless, the administration of zinc oxide NPs (ZnO-NPs) to female Wistar rats  
at a concentration of 333.33 mg/kg did not alter serum sex hormone levels such as FSH, LH and  
estradiol [91]. Once again the conflicting results observed in these two studies may be related to 
several factors such as the different type and size of NPs, and the varying doses of exposure and length 
of treatment. With regard to the latter parameter, it is worth noting that a subchronic intragastric 
exposure (90 days) [86] was able to induce a significant increase in estradiol levels, whereas acute 
administration via the same route [91] failed to determine hormonal alterations. This highlights the 
need, when extrapolating results from in vivo studies, to carefully evaluate also the periods of time 
used for an investigation. Finally, with regard to NRDE-NPs, exposure of pregnant Fischer 344 rats to 
148.86 µg/m3 of these NPs led to an increase in LH and a reduction in progesterone levels, whereas no 
significant differences were observed in FSH, prolactin, ir-inhibin and testosterone levels [90]. 
As observed for the male reproductive system the effects reported in these studies are largely 
dependent on many factors related to the experimental design and the physico-chemical characteristics 
of the NPs investigated. Evaluation of these results should therefore take these variables into account. 
Moreover, when analysing the endocrine effects on the female reproductive system, it should be noted 
that the exposure concentrations used in both in vitro and in vivo studies were very high, up to 5 mg/L 
and 333.33 mg/kg, respectively. 
2.3. Estrogenic Effects of NPs 
Several in vivo studies have investigated the potential estrogenic effects of different types of NPs in 
male and female organisms (see Table 4). However, their findings are limited, fragmentary and often 
conflicting, especially with regard to the adverse effects on male organisms. 
The estrogenic effects of Ag-NPs and QDs were investigated in aquatic species through the analysis 
of two proteins: vitellogenin (VTG), the yolk-precursor lipoprotein, and choriogenin (Chg), the 
precursor protein of the inner layer subunits egg envelope (chorion) of the teleosts which are under 
estrogenic control and consequently have a role as a biomarker of estrogens and endocrine disruption 
in oviparous organisms. In this context, Pham et al. [92] observed a conspicuous mRNA induction of 
VTG-1 and Chg-L in the livers of male Medaka (Oryzias latipes) fish exposed to Ag-NPs at 
concentrations of 1 and 25 μg/L. On the contrary, exposure of sexually immature rainbow trout 
(Onchorynchus mykiss) to concentrations of Ag-NPs ranging from 0 to 6 μg/L induced a significant 
reduction in liver expression of VTG-like proteins [93]. Similarly, studies to investigate the estrogenic 
effects of QDs also provided conflicting results since the administration of (CdS)/CdTe capped-QDs at 
doses of 1, 2 and 6 µg/L induced a clear up-regulation of VTG and a down-regulation of its receptor in 
juvenile rainbow trout (Oncorhynchus mykiss) [94], while the exposure of male sticklebacks 
(Gasterosteus aculeatus) to 0–500 μg/L of CdS-QDs failed to show any alteration in VTG expression [95]. 
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With regard to the effects caused by Ag-NPs the different induction of VTG could be due to the 
variation in exposure doses used in the studies of Pham et al. [92] and Gagnè et al. [93] (1, 25 μg/L vs. 
0.06, 0.6 and 6 μg/L, respectively). Neverthless, in the QD studies the up-regulation of VTG was 
evident at the lowest exposure concentrations (1, 2 and 6 µg/L vs. 0–500 μg/L) thus suggesting that the 
effects may be correlated to other aspects such as the different functionalization of QDs. However,  
an assessment of these estrogenic effects should take into consideration differencies in species and  
sexual maturation. 
Likewise, the evaluation of progesterone production in male laboratory animals exposed to  
NRDE-NPs did not provide consistent results. In fact, Li et al. [96] demonstrated a lower basal release of 
progesterone and corticosterone from adrenal cells obtained from male C57BL/Jcl mice exposed  
to 152.01 µg/m3 of NRDE-NPs, while greater concentrations were determined in the low-dose  
(41.73 µg/m3) NRDE-NP treated group compared to controls. However, the same research group 
observed increased plasma progesterone levels in male F344 rats exposed to middle (36.35 μg/m3)  
or high (168.84 μg/m3) NRDE-NP concentrations and decreased hormone levels in rats  
administered with low (15.37 μg/m3) or high (168.84 μg/m3) NRDE-NP doses after 4 and 8 weeks 
treatment, respectively [33]. Furthermore, immature male F344 rats prenatally exposed to the  
same NPs (148.86 μg/m3 to pregnant mice) showed significantly reduced serum progesterone  
concentrations [34]. Finally, a study on the estrogenic effects of carbon-based NPs reported that 
treatment of male zebrafish (Danio rerio) with C60 fullerene reduced the biodisponibility of the 
synthetic estrogen, 17α-ethinylestradiol [97,98]. 
In female organisms, the estrogenic effects of QDs and CB-NPs appear to be more evident. In fact 
Jain et al. [99] demonstrated the metalloestrogenic effects of CdTe-QDs on human breast cancer  
MCF-7 cells. These NPs were found to induce estrogen-related genomic and non-genomic signaling 
pathways and increase estrogen receptor-α activation and biphasic phosphorylation of AKT  
and ERK1/2, similar to 17β-estradiol action [99]. In the same study, the treatment of BALB/C 
prepubescent and virgin ovariectomized female mice with CdTe-QDs caused a two to three fold 
increase in uterine weight, comparable or greater than that induced by 17β-estradiol. Interestingly, 
these results suggest that Cd2+ released by CdTe-QDs is able to bind to the estrogenic receptor (ER). 
Exposure of C57BL/6 mice to CB-NPs at a total dose of 11, 54 and 268 μg/kg body weight during 
gestation, induced a significantly earlier onset of puberty in the offspring, assessed as time of vaginal 
opening [100]. 
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Table 4. Estrogenic effects of N
Ps. 
Type of 
study 
Type and physico-chemical properties 
of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
Results 
References 
In vitro 
C
dTe-Q
D
s (~3 nm
) 
Treatm
ent w
ith 0.5 and 10 µg/m
L 
for tim
e periods ranging from
 5 m
in 
to 96 h 
H
um
an breast 
cancer M
C
F-7 cells 
x 
C
dTe-Q
D
s induced 
estrogen-related genom
ic 
and non-genom
ic signaling 
pathw
ay;  
Increased estrogen receptor- α 
activation and biphasic 
phosphorylation of A
K
T and 
ER
K
1/2. 
[99] 
In vivo 
C
dS-Q
D
s (4.2 ± 1 nm
) 
Exposure for 21 days to 5, 50 and 
500 µg/L of C
dS-Q
D
s 
M
ale sticklebacks 
(Gasterosteus 
aculeatus) 
x 
Induction of V
TG
 synthesis 
w
as not detected in any of 
the treatm
ent groups. 
[95] 
In vivo 
N
R
D
E-N
Ps—
A
verages of m
ode diam
eter 
and num
ber concentrations for low
, 
m
iddle and high doses w
ere 22.48, 26.13 
and 27.06 nm
; 2.27 × 10
5, 5.11 × 10
5 and 
1.36 × 10
6, respectively 
Inhalation exposure to low
 (15.37), 
m
iddle (36.35) and high  
(168.84) µg/m
3 doses for 4, 8, or  
12 w
eeks (5 hours/day,  
5 days/w
eek) 
Fischer F344 rats 
x 
H
igher plasm
a progesterone 
levels after exposure for  
4 w
eeks to m
iddle or high 
N
R
D
E-N
Ps concentrations;  
Low
er plasm
a progesterone 
levels in rats treated w
ith 
low
 or high N
R
D
E-N
Ps 
after 8 w
eeks. 
[33] 
In vivo 
N
R
D
E-N
Ps—
A
verages of m
ode diam
eter 
and num
ber concentrations w
ere 26.81 
nm
 and 1.83 × 10
6, respectively 
Inhalation exposure to  
148.86 µg/m
3for 5 h daily for 19 
gestational days  
Pregnant Fischer 
F344 rats  
x 
Significantly decreased 
serum
 progesterone 
concentrations in m
ale 
offspring. 
[34] 
In vivo 
(C
dS)/C
dTe capped-Q
D
s 
Exposure for 48 h to increasing 
concentrations of (C
dS)/C
dTe 
capped-Q
D
s (1, 2 and 6 µg/L) 
Juvenile rainbow
 
trout (Oncorhynchus 
mykiss) 
x 
U
p-regulation of V
TG
;  
D
ow
n-regulation of V
TG
 
receptor. 
[94] 
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Table 4. Cont. 
Type of 
study 
Type and physico-chemical properties 
of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
Results 
References 
In vivo 
C
60  fullerene 
M
ale zebrafish (D
anio rerio) w
ere 
fed for 5 days w
ith brine shrim
p 
preparations that had accum
ulated a 
m
ixture of C
60  fullerene (10%
 v/v of 
the 600 m
g C
60/900 m
L w
ater) and 
1 μg/L of 17α-ethinylestradiol or 
C
60  fullerene or  
17α-ethinylestradiol alone.  
M
ale zebrafish 
(Danio rerio) 
x 
The treatm
ent w
ith C
60  
fullerene reduced the 
biodisponibility of synthetic 
estrogen,  
17α-ethinylestradiol. 
[97] 
In vivo 
C
B
-N
Ps (50–60 nm
) 
Intratracheal instillation at a total 
dose of 11, 54 and 268 μg/anim
al 
during gestation (7, 10, 15 and  
18 gestation days) 
C
57B
L/6 m
ice 
x 
E
xposure to 11 μg/anim
al 
induced a significantly 
earlier onset of puberty, 
assessed as tim
e of vaginal 
opening. 
[100] 
In vivo 
C
60  fullerene 
Exposure of m
ale zebrafish  
(Danio rerio) to increasing 
concentrations of C
60  fullerene.  
See Park et al. (2010)  
M
ale zebrafish 
(Danio rerio) 
x 
B
ioavailability of  
17α-ethinylestradiol w
as 
reduced w
ith increasing 
concentration of C
60  
fullerene and w
as related to 
com
puted surface area of 
C
60  fullerene. 
[98] 
In vivo 
A
g-N
Ps (20 nm
) 
Exposure to increasing 
concentrations of A
g-N
Ps (0.06, 0.6 
and 6 µg/L) for 96 h 
Juvenile rainbow
 
trout (Oncorhynchus 
mykiss) 
x 
A
g-N
Ps induced a 
significant decrease in liver 
expression of V
TG
-like 
proteins. 
[93] 
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Table 4. Cont. 
Type of 
study 
Type and physico-chemical properties 
of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
x 
Results 
References 
In vivo 
N
R
D
E-N
Ps Low
 dose group (average of 
m
ode diam
eter: 22.78 ± 0.39 nm
; m
ass 
concentration: 41.73 ± 0.58 µg/m
3; 
num
ber concentration:  
8.21 × 10
5 ± 3.1 × 10
5), H
igh dose group 
(average of m
ode diam
eter: 26.31 ± 0.38 
nm
; m
ass concentration:  
152.01 ± 1.18 µg/m
3; num
ber 
concentration: 1.8 × 10
6 ± 5.18 × 10
5)  
Exposure for 8 w
eeks (5 h/day,  
5 days/w
eek) to 41.73 µg/m
3 and 
152.01 µg/m
3 of N
R
D
E-N
Ps 
M
ale C
57B
L/Jcl 
m
ice 
x 
C
orticosterone and 
progesterone concentrations 
increased significantly in 
m
ice exposed to low
 
concentration;  
C
orticosterone and 
progesterone concentrations 
decreased significantly in 
m
ice exposed to  
high-concentration. 
[96] 
In vivo 
A
g-N
Ps (23.5 ± 4.4 nm
) 
Exposure to 1 and 25 µg/L of  
A
g-N
Ps for 28 days 
M
ale M
edaka 
(Oryzias latipes) 
fish 
x 
C
onspicuous m
R
N
A
 
induction of V
TG
-1 and 
C
hg-L in livers of  
exposed fish. 
[92] 
A
g-N
Ps, Silver N
anoparticles; A
K
T, serine/threonine-protein kinases; C
B
-N
Ps, C
arbon B
lack N
anoparticles; C
dS-Q
D
s, C
adm
ium
 Sulfide Q
uantum
 D
ots; C
dS/C
dTe 
capped-Q
D
s, C
adm
ium
 Sulfide/C
adm
ium
 Tellurium
 capped-Q
uantum
 D
ots; C
dTe-Q
D
s, C
adm
ium
 Tellurium
 Q
uantum
 D
ots; C
hg-L, choriogenin L; ER
K
, extracellular 
signal-regulated kinase; N
R
D
E-N
Ps, N
anoparticle-R
ich D
iesel Exhaust N
anoparticles; V
TG
, V
itellogenin. 
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3. Impact of Endocrine Disrupting NPs on Thyroid Function 
Thyroid hormones are involved in numerous physiological processes as regulators of metabolism, 
bone remodeling, cardiac function and mental status. Moreover, thyroid hormones are of special 
importance in fetal development, particularly in brain development, since the absence or alteration of 
their physiological levels reduces neuronal growth and differentiation in the cerebral cortex, 
hippocampus, and cerebellum [101,102]. In recent years, epidemiological studies have indicated that 
even minor changes in thyroid homeostasis may affect fetal neurological development [103]. Since 
exposure to thyroid EDCs may significantly affect public health, and studies on most chemicals with 
thyroid-disrupting potential have been sporadic and have failed to provide consistent results [104], 
there is clearly a need to evaluate the possible action of endocrine disrupting NPs on thyroid function.  
To date, in both in vitro and in vivo models, conflicting results have been reported regarding the role 
that different metal-based NPs and QDs play in influencing thyroid hormonal pathways (see Table 5). 
Hinther et al. [105] investigated the effects of exposure to Ag-NPs, ZnO-NPs and QDs on thyroid 
hormone (TH) signalling in frog tissue using a cultured tail fin biopsy assay derived from Rana 
catesbeiana tadpoles. Results showed that exposure to 5–10 nM of Ag-NPs and to 0.1 nM of QDs 
alone induced a reduction in levels of transcripts encoding the TH-induced receptor β (TRβ) and  
TH-repressed Rana larval keratin type I (RLKI), whereas treatment with ZnO-NPs had no effect on 
TRβ and RLKI transcript levels. Furthermore, Ag-NPs were able to affect TH-action on TRβ and 
RLKI transcripts according to a nonmonotonic ―inverted-U‖ hormesis response that is characteristic of 
endocrine disruption. In contrast, the administration of chromium NPs (Cr-NPs) to heat-stressed 
Sprague-Dawley rats did not bring about significant modifications in thyrotropic-stimulating hormone 
(TSH), free triiodothyronine (FT3) and free thyroxine (FT4) serum levels, indicating that these NPs do 
not affect the metabolism of thyroid hormones [106]. 
Clearly, current data concerning the impact of endocrine disrupting NPs on thyroid function are 
conflicting and very limited. Moreover, since and adequate comparison of findings cannot be made on 
account of differences in experimental conditions, it is not possible to evaluate the overall effects of 
NPs on thyroid. 
4. Impact of Endocrine Disrupting NPs on Insulin Action and Metabolism 
The findings of several toxicology and epidemiology studies have suggested that various EDCs are 
involved in an increasing number of metabolic disorders, including insulin resistance (IR) and  
IR-related co morbidities, such as obesity, type 2 diabetes mellitus (T2DM) and polycystic ovary 
syndrome [12,107,108]. These particular EDCs are also known as metabolic disruptors [109]. 
Recently, a number of in vitro and in vivo studies have evaluated possible metabolic disruption  
of insulin-signalling pathways and insulin production caused by exposure to different metal-based  
NPs (see Table 5). 
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Table 5. O
ther effects of N
Ps on endocrine system
. 
Type of 
study 
Type and physico-chemical 
properties of NPs 
Experimental protocol 
Cell 
line/laboratory 
animals 
Results 
References 
Effects on thyroid function 
In vitro 
A
g-N
Ps (2–6 and 10 nm
), 
ZnO
-N
Ps (2–10 and 9 nm
) and 
Q
D
s com
posed of cadm
ium
 
telluride (2–10 and 10–15 nm
) 
Exposure of cultured tail fin biopsy to 
0.06 μg/L
–5.5 m
g/L of A
g-N
Ps,  
0.19–10 m
g/L of ZnO
-N
Ps and  
0.25 μg/L
–22 m
g/L of Q
D
s for 48 h 
C
ultured tail fin 
biopsy assay 
derived from
  
Rana catesbeiana 
tadpoles 
x 
R
educed levels of transcripts encoding 
T
R
β and R
L
K
I w
ere induced by 
exposure to 5–10 nM
 of A
g-N
Ps and to 
0.1 nM
 of Q
D
s;  
Treatm
ent w
ith ZnO
-N
Ps had no effect 
on T
R
β and R
L
K
I transcript levels;  
A
g-N
Ps w
ere able to affect the  
TH
-action on T
R
β and R
LK
I transcripts 
according to an ―inverted-U
‖ horm
esis 
response. 
[105] 
In vivo 
C
r-N
Ps (40–70 nm
) 
O
ral adm
inistration of 150, 300 and 
450 µg/K
g of C
r-N
Ps for 8 w
eeks 
M
ale Sprague 
D
aw
ley rats 
x 
C
r-N
Ps did not result in significant 
m
odifications in TSH
, FT
3  and FT
4  
serum
 levels. 
[106] 
Effects on insulin action and metabolism
 
In vitro 
TiO
2 -N
Ps (21 nm
) 
E
xposure for 2 h to 50 and 200 μg/m
L 
of TiO
2 -N
Ps 
Fao rat hepatom
a 
cells 
x 
TiO
2 -N
Ps im
paired insulin response 
and induced insulin resistance. 
[110] 
In vitro  
C
eO
2 -N
Ps (100 nm
) 
Exposure to 100 nm
ol/L of  
C
eO
2 -N
Ps, alone or in com
bination 
w
ith 30 nm
ol/L of sodium
 selenite 
for 1–6 days 
Pancreatic islets 
x 
Increased cell viability, A
TP/A
D
P ratio 
and secretion of insulin in response to 
glucose stim
uli. 
[111] 
In vivo 
C
rC
l3 -N
Ps (40–70 nm
) 
D
ietary supplem
entation for 35 days 
w
ith 200 μg/kg of C
rC
l3 -N
Ps 
C
rossbred pigs 
(D
uroc X
 Landrace 
X
 Y
orkshire) 
x 
The treatm
ent w
ith C
rC
l3 -N
Ps  
reduced serum
 insulin and cortisol 
levels and increased serum
 insulin-like 
grow
th factor. 
[112] 
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Table 5. Cont. 
Type of 
study 
Type and physico-chemical properties 
of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
Results 
References 
Effects on insulin action and metabolism
 
In vivo 
C
r-N
Ps (40–50 nm
) 
O
ral adm
inistration for  
6 w
eeks of 75, 150, 300, 
450, 600 and 1200 ppb of 
C
r-N
Ps 
M
ale Sprague D
aw
ley 
rats 
x 
A
ddition of 300 and 450 ppb of  
C
r-N
Ps reduced the serum
 insulin 
level. 
[113] 
In vivo 
C
r-N
Ps (40–70 nm
) 
O
ral adm
inistration of 
150, 300 and 450 µg/K
g 
of C
r-N
Ps for 8 w
eeks 
M
ale Sprague D
aw
ley 
rats 
x 
D
ietary supplem
entation of 150, 
300, and 450 μg/kg significantly 
decreased serum
 concentrations of 
insulin and cortisol and increased 
sera levels of IG
F-I. 
[106] 
In vivo 
D
ouble w
alled-CN
Ts (0.5–2.5 nm
 for inner 
tubes and 1.2–3.2 nm
 for outer tubes) 
Intranasal instillation of 
1.5 m
g/kg 
M
ale Sw
iss m
ice 
x 
Increased serum
 levels of IG
F-1. 
[114] 
In vivo 
C
eO
2 -N
Ps 
Intraperitoneal injection of 
60 m
g/K
g of CeO
2 -N
Ps for 
2 w
eeks, alone or in 
com
bination w
ith sodium
 
selenite (5 μm
ol/kg/day)  
M
ale W
istar rats 
x 
Im
provem
ent in biom
arkers of 
diabetes (oxidative stress, A
D
P/A
TP, 
glycem
ic and lipid profile). 
[115] 
Effects on neuroendocrine system 
In vitro 
C
60  fullerene  
Exposure for 4 h to  
100 µM
 of C
60  fullerene 
A
drenal chrom
affin 
cells obtained from
 
W
istar rats 
x 
Treatm
ent w
ith C
60  fullerene notably 
increased cell survival and prevented 
cell death, including apoptosis. 
[116] 
In vitro 
M
nO
-N
Ps (40 nm
) and A
g-N
Ps (15 nm
) 
Exposure for 24 h to 
increasing concentrations 
(1–100 µg/m
L ) of N
Ps 
PC
-12 cells  
derived from
  
Rattus norvegicus 
pheochrom
ocytom
a 
(C
R
L-1721) 
x 
M
nO
-N
P dose dependently depleted 
D
A
 and D
O
PA
C
; 
x 
A
g-N
Ps significantly reduced D
A
 and 
D
O
PA
C at concentrations of 50 µg/m
L; 
x 
H
V
A
 levels decreased at 50 µg/m
L in 
both M
nO
-N
P and A
g-N
P exposure. 
[117] 
Int. J. M
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Table 5. Cont. 
Type of 
study 
Type and physico-chemical properties 
of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
Results 
References 
Effects on neuroendocrine system
 
In vitro 
C
u-N
Ps (90.9 ± 19.3 nm
),  
M
n-N
Ps (52.1 ± 23.8 nm
) and  
A
g-N
Ps (18.3 ± 7.3 nm
) 
Treatm
ent for 24 h w
ith 
10 µg/m
L of N
Ps and 
w
ith increasing 
concentrations of C
u-N
Ps 
(2.5, 5, 7.5, 10 and  
25 µg/m
L) 
PC
-12 cells 
x 
C
u-N
Ps induced a significant 
reduction in the content of D
A
, 
D
O
PA
C
, and H
V
A
 in PC
12 cells. 
[118] 
In vitro 
A
u-N
Ps (28 nm
) and A
g-N
Ps (61 nm
) 
Treatm
ent for 24 and 48 h 
w
ith 0.01–1 nM
 of N
Ps 
Prim
ary culture 
m
urine adrenal 
m
edullary chorm
affin 
cells harvested from
 
w
ild-type brow
n m
ale 
m
ice (C
57B
L/6J) 
x 
Exposure to A
u-N
Ps and A
g-N
Ps 
caused low
er and slow
er secretion of 
epinephrine m
olecules. 
[119] 
In vitro 
C
arboxyl Q
D
s w
ith C
dSe core and ZnS 
shell (7–8 nm
) 
Exposure for 24 h to 
increasing concentrations 
of Q
D
s (5, 8, 16 and  
36 nM
) 
M
ouse chrom
affin 
cells obtained from
 
young C
57B
L/6J 
m
ale m
ice 
x 
Exposure to carboxyl Q
D
s w
ith 
C
dSe core and ZnS shell im
pairs 
C
a
2+ influx and severely interferes 
w
ith the functionality of the 
exocytotic m
achinery, 
com
prom
ising the overall 
catecholam
ine supply from
 
chrom
affin cells. 
[120] 
In vitro 
A
g-N
Ps coated w
ith citrate (6 nm
) or 
polyvinylpyrrolidone (21 nm
) 
Exposure for 24 h to 
different concentrations 
(1–30 µM
) of A
g-N
Ps 
PC
-12 cells 
x 
Treatm
ent w
ith citrate- coated  
A
g-N
Ps reduced the em
ergence of 
the acetylcholine-phenotype;  
Treatm
ent w
ith polyvinylpyrrolidone 
-coated A
g-N
Ps enhanced 
differentiation into a D
A
-phenotype. 
[121] 
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Table 5. Cont. 
Type of 
study 
Type and physico-chemical 
properties of NPs 
Experimental protocol 
Cell line/laboratory 
animals 
Results 
References 
Effects on neuroendocrine system
 
In vitro 
Silica N
Ps (15 nm
) 
Exposure for 24 h to  
25–200 μg/m
L of silica N
Ps 
PC
-12 cells 
x 
Silica N
Ps exerted a dose-dependent 
reduction in D
A
 synthesis related to 
redundant R
O
S generation in  
the cells. 
[122] 
In vitro 
C
itrated-capped A
g-N
Ps  
(from
 15 to 60 nm
); PEG
 
(25.6 ± 7.8 nm
) and heparin 
(20.6 ± 15.3 nm
) surface 
m
odified A
u N
Ps. 
Exposure for 24 h to  
citrated-capped A
g-N
Ps at  
1 nM
 concentration and to 
PEG
 and heparin A
u N
Ps at 
10 µg/m
L 
Prim
ary culture m
urine 
adrenal m
edullary 
chorm
affin cells harvested 
from
 w
ild-type brow
n m
ale 
m
ice (C
57B
L/6J) 
x 
N
oble m
etal N
Ps disrupt exocytosis, 
typically altering the num
ber of 
m
olecules and kinetics of release. 
[123] 
Effects on pituitary gland 
In vivo 
C
rC
l3 -N
Ps (40–70 nm
) 
D
ietary supplem
entation for 
35 days w
ith 200 μg/kg of 
C
rC
l3 -N
Ps 
C
rossbred pigs (D
uroc X
 
Landrace X
 Y
orkshire) 
x 
N
o significant difference in G
H
 level 
betw
een exposed and control group. 
[112] 
In vivo 
C
rC
l3 -N
Ps (40–70 nm
) 
D
ietary supplem
entation for 
35 days w
ith 200 μg/kg of 
C
rC
l3 -N
Ps 
C
rossbred pigs (D
uroc X
 
Landrace X
 Y
orkshire) 
x 
C
rC
l3 -N
Ps significantly increased the 
m
ean level, low
est value, peak value and 
peak duration of G
H
;  
Pituitary m
R
N
A
 expression of G
H
 
im
proved significantly. 
[124] 
In vivo 
C
r-N
Ps (40–70 nm
) 
O
ral adm
inistration of 150, 
300 and 450 µg/K
g of C
r-N
Ps 
for 8 w
eeks 
M
ale Sprague D
aw
ley rats 
x 
N
o significant alterations in the 
concentrations of pituitary produced G
H
. 
[106] 
Effects on adrenal gland 
In vivo 
N
R
D
E-N
Ps—
A
verages of 
m
ode diam
eter and num
ber 
concentrations for low
, 
m
iddle and high doses w
ere 
22.48, 26.13 and 27.06 nm
; 
2.27 × 10
5, 5.11 × 10
5 and 
1.36 × 10
6, respectively 
Inhalation exposure to low
 
(15.37), m
iddle (36.35) and 
high (168.84) µg/m
3 doses for 
4, 8, or 12 w
eeks (5 h/day,  
5 days/w
eek) 
Fischer F344 rats 
x 
N
o significant differences in plasm
a 
concentrations of corticosterone w
ere 
observed in the different exposure 
groups. 
[33] 
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Table 5. Cont. 
Type of 
study 
Type and physico-chemical properties  
of NPs 
Experimental protocol 
Cell line/ 
laboratory 
animals 
Results 
References 
Effects on adrenal gland 
In vivo 
N
R
D
E-N
Ps—
A
verages of m
ode diam
eter and 
num
ber concentrations w
ere 26.81 nm
 and 
1.83 × 10
6, respectively 
Inhalation exposure to  
148.86 µg/m
3for 5 h daily for 19 
gestational days  
Pregnant 
Fischer F344 
rats  
x 
Significantly low
er 
corticosterone concentrations 
w
ere observed in m
ale 
offspring. 
[34] 
In vivo 
C
r-N
Ps (40–70 nm
) 
O
ral adm
inistration of 150, 300 
and 450 µg/K
g of C
r-N
Ps for  
8 w
eeks 
M
ale Sprague 
D
aw
ley rats 
x 
Exposure to C
r-N
Ps decreased 
plasm
a cortisol levels. 
[106] 
In vivo 
N
R
D
E-N
Ps Low
 dose group (average of 
m
ode diam
eter: 22.78 ± 0.39 nm
; m
ass 
concentration: 41.73 ± 0.58 µg/m
3; num
ber 
concentration: 8.21 × 10
5 ± 3.1 × 10
5), H
igh 
dose group (average of m
ode diam
eter:  
26.31 ± 0.38 nm
; m
ass concentration:  
152.01 ± 1.18 µg/m
3; num
ber concentration: 
1.8 × 10
6 ± 5.18 × 10
5)  
Exposure for 8 w
eeks  
(5 h/day, 5 days/w
eek) to  
41.73 µg/m
3 and  
152.01 µg/m
3 of  
N
R
D
E-N
Ps 
M
ale 
C
57B
L/Jcl 
m
ice 
x 
A
t the highest exposure dose, 
N
R
D
E-N
Ps inhibited basal and 
A
C
TH
-stim
ulated  
corticosterone release;  
The low
est N
R
D
E-N
P 
concentration increased 
synthesis and release  
of corticosterone. 
[96] 
In vivo 
N
R
D
E-N
Ps (22–27 nm
; particle com
position 
show
ed a higher percentage of organic carbon 
than elem
ental carbon) 
Inhalation exposure to 148.86 
µg/m
3 for 5 h daily from
 day 1 to 
19 of gestation  
Pregnant 
Fischer 344 
rats 
x 
Increased serum
 levels  
of corticosterone. 
[90] 
A
C
TH
, A
drenoC
orticoTropic H
orm
one; A
D
P, A
denosine D
iphosphate; A
TP, A
denosine Triphosphate; A
g-N
Ps, Silver N
anoparticles; A
u-N
Ps, G
old N
anoparticles; 
C
dSe, C
adm
ium
 Selenium
; C
eO
2 -N
Ps, C
erium
 O
xide N
anoparticles; C
N
Ts, C
arbon N
anotubes; C
r-N
Ps, C
hrom
ium
 N
anoparticles; C
rC
l3 -N
Ps, C
hrom
ium
 C
hloride 
N
anoparticles; C
u-N
Ps, C
opper nanoparticles; D
A
, D
opam
ine; D
O
PA
C
, dihydroxyphenylacetic acid; FT
3 , free triiodothyronine; FT
4 , free thyroxine; G
H
, G
row
th 
H
orm
one; H
V
A
, H
om
oV
anillic A
cid; IG
F-I, Insulin-like G
row
th Factor I; M
n-N
Ps, M
anganese N
anoparticles; M
nO
-N
Ps, M
anganese O
xide N
anoparticles; N
R
D
E-N
Ps, 
N
anoparticle-R
ich D
iesel Exhaust N
anoparticles; PEG
, PolyEthylene G
lycol; Q
D
s, Q
uantum
 D
ots; R
LK
I, R
ana Larval K
eratin Type I; R
O
S, R
eactive O
xygen Species; 
TiO
2 -N
Ps, Titanium
 D
ioxide nanoparticles; TR
β, Thyroid horm
one R
eceptor β; TSH
, Thyrotropic-Stim
ulating H
orm
one; ZnO
-N
Ps, Zinc O
xide N
anoparticles; ZnS,  
Zinc Sulfide. 
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In this context, Gurevitch et al. [110] investigated the potential role of TiO2-NPs in the etiology of 
metabolic/endocrine disorders such as obesity and closely- related IR. In this study, the exposure  
of Fao rat hepatoma cells to 50 and 200 μg/mL of TiO2-NPs impaired insulin response and induced 
insulin resistance through direct interference with insulin-signalling pathways and indirect 
inflammatory activation of the macrophages. In another in vitro study, an increase in cell viability, 
ATP/ADP ratio and secretion of insulin in response to glucose stimuli was observed in isolated 
pancreatic islets treated with CeO2-NPs at a concentration of 100 nmol/L, either alone or in 
combination with 30 nmol/L sodium selenite [111].These findings could possibly be ascribed to the 
proinflammatory action of TiO2-NPs [110] and to the anti-oxidant potential of CeO2-NPs [111] which 
may exert a different effect on the insulin cascade and release, respectively.  
In contrast, dietary addition of 300 and 450 μg/kg of Cr-NPs caused a significant decrease in serum 
insulin levels in Sprague-Dawley rats [113]. Similarly, lower concentrations of insulin and cortisol and 
higher levels of insulin growth-factor (IGF)-1 were detected in the same animal model treated with a 
basal diet supplemented with 150–450 μg/kg of Cr-NPs [106]. Comparable results were obtained by 
Wang et al. [112] when administering 200 μg/kg of Cr-NPs to crossbred pigs, while an increase in 
serum levels of IGF-1 was reported in Swiss mice intranasally instilled with 1.5 mg/kg of double 
walled-CNTs [114]. The reduction in peripheral insulin levels may have been due to an enhanced 
binding of insulin to its receptors on targeted tissues such as muscle and fat since Cr is thought to 
facilitate the interactions between insulin and insulin receptors and to promote hormone internalization 
into cells [125]. The same Authors provided confirmation of the protective effects of CeO2-NPs on 
pancreatic islets in streptozotocin induced diabetic Wistar rats intraperitoneally injected with these NPs 
(60 mg/kg) alone, or in combination with sodium selenite (5 μmol/kg/day). The findings of this study 
showed a significant improvement in diabetes biomarkers including oxidative stress, energy 
compensation (ADP/ATP), and the glycemic and lipid profile [115]. 
5. Impact of Endocrine Disrupting NPs on the Neuroendocrine System 
Chromaffin cells are neuroendocrine cells found mainly in the medulla of the adrenal gland and in 
other ganglia of the sympathetic nervous system. In these cells the release of numerous catecholamines 
into the blood e.g., adrenaline, noradrenaline, enkephalin and a range of biologically active peptides 
occurs through multiple intracellular (chromaffin cell excitability, Ca2+ signaling, exocytosis, 
endocytosis) and intercellular pathways (splanchnic nerve-mediated synaptic transmission, paracrine 
and endocrine communication, gap junctional coupling) in response to a wide variety of stress-related 
signals [126,127]. Chronic hypoxia is also included among these signals and can significantly affect 
catecholamine secretion by increasing the number of secreted vesicles at low voltages, although it does 
not alter the mechanism of catecholamine release [128]. Catecholamine secretion usually takes place in 
situations of fear, anxiety or organic stress. However, the release of hormones from adrenomedullary 
chromaffin cells can also be triggered by a number of chemicals that reach the adrenal medulla via the 
bloodstream [129]. For this reason, in recent years several in vitro studies have been performed in 
order to verify the endocrine disrupting activity of NPs (especially metal-based NPs), on chromaffin 
cells (see Table 5). Study findings have shown that NPs have the potential to disrupt the physiological 
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function of neuroendocrine cells by altering their catecholamine levels or compromising the  
exocytotic machinery.  
Hussain et al. [117] observed a dose-dependent depletion of dopamine (DA) and 
dihydroxyphenylacetic acid (DOPAC) in PC-12 cells exposed to 1–100 µg/mL of manganese oxide  
NPs (MnO-NPs). In the same study, treatment with Ag-NPs induced similar results but only  
at a concentration of 50 µg/mL, while homovanillic acid (HVA) levels decreased at 50 µg/mL in both  
MnO-NP and Ag-NP exposure. Comparable results were obtained by Wang et al. [118] who, on 
exposing PC-12 cells to increasing concentrations of copper NPs (Cu-NPs), found a significant 
reduction in the levels of DA, DOPAC and HVA, probably caused by oxidative stress and enzymatic 
alterations. The toxicological behavior of citrate-reduced Au-NPs and Ag-NPs was studied by Love 
and Haynes [119] on primary cultures of adrenal medullary chromaffin cells. Treatment with  
0.01–1 nM of metal-based NPs did not affect cell viability, but caused less and slower secretion  
of epinephrine molecules, indicating the ability of these NPs to interfere with chemical messenger 
delivery and the vesicular kinetic. These findings were confirmed by a subsequent study conducted on 
murine adrenal medullary chromaffin cells exposed to different sizes of Ag-NPs (1 nM) and to 
polyethilen-glycol (PEG) and heparin surface-modified Au-NPs (10 µg/mL). In fact, the results of this 
study showed that noble metal NPs disrupt exocytosis, typically by altering the number of molecules 
and release kinetics, and enhance direct disruption of the vesicle matrix [123]. The functionality of the 
exocytotic machinery of mouse (C57BL/6J) chromaffin cells was also severely damaged by exposure 
to 5–36 nM of carboxyl QDs with CdSe core and ZnS shell since these were able to impair Ca2+ influx 
and consequently compromise the overall catecholamine supply from chromaffin cells [120]. 
Interestingly, Ag-NP (coated with citrate or polyvinylpyrrolidone) exposure (30 μM) also impairs 
neurodevelopment in PC12 cells as demonstrated by a depleted emergence of the acetylcholine-phenotype 
and an enhanced differentiation into a DA-phenotype after treatment with citrate-coated Ag-NPs and 
polyvinylpyrrolidone-coated Ag-NPs, respectively [121]. 
In a study on fullerene C60, Corona-Morales et al. [116] observed that exposure of Wistar rat 
adrenal chromaffin cells to 100 μM of these NPs, remarkably increased cell survival and prevented cell 
death, including apoptosis. The beneficial effects observed in this study were probably due to the 
strong antioxidant capacity of fullerene C60. Conversely, the exposure of cultured mouse chromaffin 
cells to increasing doses (30–263 μg/mL) of MWCNTs caused a dose-dependent reduction both in cell 
membrane input resistance and the number of spontaneously active cells [130]. Finally, exposure of 
the PC12 cell line to 25–200 μg/mL of silica NPs resulted in a dose-dependent reduction in DA 
synthesis associated with redundant ROS generation in the cells [122]. 
6. Other Effects of Endocrine Disrupting NPs 
A limited number of studies have investigated the adverse effects of Cr-NPs on the pituitary gland 
(see Table 5) by evaluating secretion and the levels of growth hormone (GH). The exposure of 
Sprague-Dawley rats to 150, 300, and 450 μg/kg of Cr-NPs did not cause significant alterations in the 
concentrations of pituitary-produced GH [106]. Similar results (no significant difference in GH level 
between the exposed and control groups) were obtained in crossbred pigs (Duroc x Landrace x 
Yorkshire) treated with 200 μg/kg of Cr-NPs [112], while, in a subsequent study, the same research 
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group observed that these NPs were able to alter GH pulsatile secretion and pituitary GH-mRNA 
expression by inducing an increase in the mean level, lowest value, peak value and peak duration of 
GH secretion and by significantly improving pituitary GH-mRNA expression [124]. These conflicting 
results are probably due to the different experimental design of the studies. In fact, given the  
pulsatile nature of GH release in most mammals, a measurement technique based on a single blood  
sample [112] is not sufficiently sensitive to assess the effects of treatment on GH.  
The secretory function of adrenal glands may also be affected by exposure to NPs as demonstrated 
by some ex vivo and in vivo studies carried out using NRDE-NPs (see Table 5). In fact, the treatment 
of male C57BL/Jcl mice with 41.73 µg/m3 and 152.01 µg/m3 of NRDE-NPs inhibited, at the highest 
dose, both basal and ACTH-stimulated corticosterone release by adrenal cells, while the lowest 
NRDE-NP concentration increased synthesis and release of the hormone following a biphasic dose 
response curve [96]. However, the same research group demonstrated that there were no significant 
differences in plasma corticosterone concentrations in adult male Fischer rats and in male C57BL/Jcl 
mice exposed to 15.37, 36.35 and 168.84 μg/m3 and to 41.73 µg/m3 and 152.01 µg/m3 of NRDE-NPs, 
respectively [33,96]. Conversely, an increase in serum corticosterone levels was evident in pregnant 
Fischer rats treated with NRDE-NPs (148.86 µg/m3) [90], while in immature male Fischer rats, 
prenatally exposed to these NPs, there was a significant reduction in serum hormone concentrations [34]. 
Finally, with regard to cortisol secretion, Zha et al. [106] showed that the administration of 150–450 μg/kg 
of Cr-NPs to Sprague-Dawley rats reduced plasma cortisol levels. 
7. Impact of Endocrine Disrupting NPs on Invertebrate Species 
Currently, most of the studies to assess the adverse effects of EDCs are performed on vertebrates, 
while significantly less attention is paid to the effects on invertebrates. However, invertebrates account 
for most animal biodiversity and are important in routine ecotoxicological testing and environmental 
monitoring [131]. Thus, understanding the adverse effects on invertebrate endocrinology caused by 
endocrine disrupting NPs may be useful since this species could act as sentinel organisms to evaluate 
the environmental impact of this category of endocrine disruptors. 
Several studies that evaluated the potential endocrine disrupting activity of different types  
(metal- and carbon-based NPs and QDs) of NPs in Daphnia magna, have reported a significant  
impact on the reproductive health of this invertebrate. A reduced number of offspring per female was 
observed in Daphnia magna chronically treated with different sized TiO2-NPs at concentrations 
ranging from 0.01 to 100 mg/L [132]. Similar results (reduced number of offspring and complete 
inhibition of reproduction at the highest dose) were obtained on exposing Daphnia magna to  
0.1–5 mg/L of Degussa P25 TiO2-NPs [133] or to 0.02–2 mg/L of different types of the same  
metal-based NPs for 21 days [134]. A significant inhibition of reproduction was also observed in 
Daphnia magna exposed to 5–500 μg/mL of Ag-NPs [135]. A study on carbon-based NPs, [136] 
showed that the administration of 2.5 ppm of fullerene C60 could delay molting and reduce offspring 
production in Daphnia magna, whereas at sub-lethal doses of exposure, Tao et al. [137] reported 
observing the accumulation of reproductive responses such as delayed maturation of the female 
offspring of gestating exposed daphnids and the inability to reproduce of mother daphnids after 
fullerene C60 exposure. A decrease in the total number of neonates per female was also detected for 
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nanodiamonds at concentrations ≥ 1.3 mg/L [138]. In order to assess the estrogenic effects of QDs on 
this aquatic species, Kim et al. [139] exposed juvenile Daphnia magna to concentrations ranging from 
0 to 30 μg/L of CdSe/ZnSe QDs coated with tri-n-octylphosphine oxide/gum arabic. The results of this 
study failed to reveal changes in VTG mRNA expression, however, the administration of  
3-mercaptopropionic acid-coated CdSe/ZnSe QDs with relevant levels of UV-B, induced a  
dose-dependent reduction in VTG expression. In another invertebrate aquatic organism, the marine 
amphipod Corophium volutator, exposure to 0.2–1 mg/L of ZnO-NPs caused a delay in sexual 
maturation and reduced fecundity [140]. 
The endocrine disrupting effects of metal-based NPs were also observed in Chironomus riparius 
and Drosophila Melanogaster. Exposure of Chironomus riparius midge larvae to 0–1 mg/L of these 
NPs reduced pupation, adult emergence, the male/female ratio and egg number, probably through an 
up-regulation of the gonadotropin releasing hormone (GnRH) mRNA gene expression [141]. 
Moreover, Ag-NPs may interfere with the Chironomus riparius midge ecdysteroid system by altering 
ecdysteroid receptor mRNA expression [142]. In Drosophila Melanogaster, the addition to food 
(0.005%–0.5% w/v) of TiO2-NPs and Ag-NPs led to a significant decrease in developmental success 
and, in the case of exposure to TiO2-NPs, to a significant progeny loss, as shown by the decline in 
female fecundity. Similarly, a substantial reduction in the Drosophila melanogaster lifespan  
and fertility performance was observed after the ingestion of 0.114–467 mg/g of citrate-capped  
Au-NPs [143]. 
A number of studies have reported reproductive toxicity in worms in a terrestrial environment due 
to various metal oxide NPs. Five days of dietary exposure to TiO2-NPs (>47.9 mg/L), ZnO-NPs  
(1.2 and 4.6 mg/L) and Al2O3-NPs (>102 mg/L) reduced nematode Caenorhabditis Elegans growth, 
the number of eggs and offspring per worm, indicating NP-induced reproductive impairment in this 
species [144,145]. Comparable results that demonstrated the ability of metal-based NPs (Ag-NPs, 
CeO2-NPs, TiO2-NPs and ZnO-NPs) to affect the reproductive potential of Caenorhabditis Elegans 
were obtained by Roh et al. [146,147] and by Ma et al. [148]. A subsequent study carried out by  
Lim et al. [149] suggested that oxidative stress was the leading mechanism in inducing Ag-NP 
reproductive impairment in this invertebrate species. In addition to metal-based NPs, QDs,  
carbon-based and silica NPs also produced significant detrimental effects on the reproductive  
function of Caenorhabditis Elegans. In fact, egg alterations were observed after exposure to 200 nM  
of CdSe/ZnS or CdTe-QDs [150], while a reduction in the reproductive rate, assessed as the number  
of eggs per animal, was induced by treatment with 100 μg/mL of hydroxylated fullerene [151]. 
Furthermore, the administration of 2.5 mg/mL of silica-NPs caused a reduction in progeny and a 
manifestly premature cessation of progeny production due to age-related degeneration of the 
reproductive organs [152]. Disruption of the reproductive function related to several types of metal, 
metal oxide and carbon-based NPs, was also observed in Eisenia fetida and Eisenia veneta 
earthworms. In fact, exposure to 2.5–25 mg/kg of Au-NPs caused a dose-dependent decrease  
in the number of offspring [153], while acute exposure to PVP-coated Ag-NPs (801 ± 74.9 and  
773.3 ± 11.2 mg/kg) [154] and treatment with 3000 and 10,000 mg/kg of Al2O3-NPs (11 nm) resulted  
in a lower number of cocoons [155]. Similar results were also observed in Eisenia fetida and  
Eisenia veneta exposed to ZnO-NPs and TiO2-NPs [156] and to ZnO-NPs [157], respectively. In 
contrast, the exposure of Eisenia fetida to Cu-NPs at concentrations of 5–50 mg/kg dry mass did not 
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cause any reproductive effects [158]. With regards to carbon-based NPs, treatment of Eisenia veneta 
earthworms with double walled-CNTs led to a significant reduction in cocoon production [159] and 
similarly, the cocoon number diminished in Eisenia veneta, Eisenia fetida and Lumbricus rebellus 
exposed to C60 fullerene [159–161]. However, a study conducted by Pakarinen et al. [162] failed to 
confirm the reproductive toxicity of C60 fullerene in Lumbriculus variegatus administered with 10 and 
50 mg/kg of the aforementioned carbon-based NPs. 
8. Discussion and Conclusions 
Recent advances in engineering and technology have led to the development of many types of NPs 
currently used in numerous industrial sectors. The rapidly developing field of nanotechnology, which 
is creating materials with size-dependent properties, is likely to become an important source of 
exposure to NPs. In fact, as more and more consumer products containing NPs become available on 
the market, exposure of the general population will inevitably increase. However, as with any new 
technology, the earliest and most extensive exposure to hazards is most likely to occur in the 
workplaces and workers in nanotechnology-related industries may be particularly exposed to uniquely 
engineered materials with innovative sizes, shapes, and physical and chemical properties. The growing 
NP exposure of workers and the general population to NPs has heightened concern about the potential 
human toxicity and environmental impact of these particles. Consequently, in the past few years, 
nanotoxicology has emerged as a new discipline designed to elucidate the relationship between the 
physical and chemical properties of NPs and the induction of toxic biological responses [163]. 
However, since there is still a lack of knowledge about the possible risks to human health and 
environmental safety posed by the expanding development and use of NPs, there seems to be an urgent 
need to gather information on this subject.  
In this context, we have summarized the data currently available in the literature that report the 
adverse effects on the endocrine system caused by in vitro and in vivo exposure to different types of 
NPs. Our aim was to understand the risk of NP endocrine disruption, assess the underlying 
mechanisms that can affect endocrine function and identify research areas where further study needs to 
be carried out to reach a deeper understanding of the role of NPs as endocrine disruptors. Current data 
support the notion that different types of NPs are capable of altering the normal and physiological 
activity of the endocrine system (see Tables 2–5). The male and female reproductive systems are the 
endocrine organs that have received most attention. In the male reproductive system (see Table 2), findings 
showed that NPs are able to affect cell viability in gonadal tissues, testicular morphology and the 
process of spermatogenesis, while in the female reproductive system (see Table 3), NPs exerted 
cytotoxic and/or genotoxic effects on ovarian structural cells and damaged oogenesis and follicle 
maturation. Furthermore, NPs caused significant alterations in normal sex hormone levels in both 
systems. However, some studies failed to confirm these adverse effects, since no abnormalities in male 
and female reproductive function were found after NP exposure (see Tables 2 and 3). These conflicting 
results are probably due to the different intrinsic properties of NPs used in the in vitro and in vivo 
studies. In fact, research has shown that the physico-chemical characteristics (particle size, shape, 
surface area, charge, chemical properties, solubility, oxidant generation potential, and degree of 
agglomeration) of NPs can influence their effects on biological systems [20].  
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This supposition is also confirmed by the findings of some of the studies reviewed, since the 
physico-chemical properties of NPs seem to influence the toxic effects induced on endocrine function. 
For instance, NP size impacted spermatogenesis, sperm quality and testosterone levels in different 
ways [47,56], while surface functionalization appeared to bring about variations in both male and 
female reproductive NP effects [39,44,47,78,81]. Moreover, Love et al. [123] suggested that different 
NP physico-chemical properties, including size and surface coating, modulate changes in the cell 
communication of murine chromaffin cells exposed to different types of Ag-NPs and  
Au-NPs. Therefore, since the biological and toxic effects of NPs are highly dependent on their  
physico-chemical properties as well as on dosage, route of administration and exposure time [41], it is 
evident that a clear and precise evaluation of the effects of NPs as endocrine disruptors should also 
include a homogeneous exposure classification to ascertain exactly how the physico-chemical 
properties of NPs correlate with their adverse effects on the endocrine system. Useful parameters for a 
systematic categorization should include chemical composition, morphology, number concentration, 
surface area, mass concentration, weighted size distribution, state of agglomeration and surface 
reactivity (e.g., the ability to produce radicals and zeta potential). This is fundamental for an 
assessment of the endocrine toxicity of NPs, but unfortunately much of this characterization is largely 
lacking in current studies. For example, most available studies provide an indication of the  
chemical composition and size of the NPs used, while only a few of the reviewed studies go  
beyond this basic information to include data on other parameters such as functionalization  
[37,39,42–44,57,69,78,81,82,84,94,120,121,123], number concentration [33,34,49,58,60,89,96], 
surface area [35,36,70,79,86,88], shape [72] and degree of aggregation [85]. 
Furthermore, in addition to the ―intrinsic‖ NP properties, it may be extremely useful to evaluate the 
properties ―extrinsically‖ acquired by NPs when interacting with biological fluids [164]. In fact, when 
NPs enter a physiological environment, they can rapidly adsorb proteins forming what is known as the 
protein corona. The protein corona provides the NPs with a biological identity that is substantially 
different from their synthetic identity [165], and, by affecting interaction with biomolecules, 
membranes and physical barriers, leads to specific toxic effects. Consequently, it is possible that quite 
different nanomaterials that share similar corona properties may have similar early biological 
interactions [164]. Interestingly, each physiological compartment has its own distinct set of proteins 
that interact in a unique way with the NPs. This is an important aspect to consider when comparing  
in vitro and in vivo experiments, but also when evaluating in vivo studies in which different routes of 
exposure were used [166]. In fact, since the protein corona reflects the traiectory of NPs in the body,  
a nanomaterial that enters the blood through the lung may have a dramatically different protein corona 
composition and resulting physiological response than the same nanomaterial directly injected into the 
blood [167]. Another important issue regarding the potential role of NPs in endocrine disruption is 
related to the molecular mechanisms of action underlying the adverse effects observed. In several 
studies, oxidative stress was hypothesized as the principal damaging mechanism [37,56,71,86]. 
However, oxidative stress is not the only mechanism of action capable of altering the functionality of 
the endocrine system, since Ag-NPs have been shown to inhibit cell proliferation by disrupting the 
proliferation signaling cascade of spermatogonial stem cells, rather than by inducing an oxidative 
reaction [47]. A similar mechanism has also been reported for SiCNWs on ovarian cells [73]. 
Furthermore, direct DNA damage has been reported as a potential toxic mechanism in mouse  
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and human spermatozoa in in vitro [45,49] and in vivo models [55,56]. Numerous studies  
have also shown that NP endocrine toxicity occurs due to its ability to modify the gene  
expression of proteins and enzymes involved in sex hormone biosynthesis, metabolism and  
release [30,33,34,59–61,86,89,90,120]. Another important mechanism of action by means of which  
EDCs are able to alter functions of the endocrine system is related to their ability to bind to hormone 
receptors. This mechanism of action may also be used by NPs and may play a significant role in the 
induction of endocrine effects. Indeed, the estrogenic effects exerted in mammalian cells and animal 
models may be dependent on NP interaction with nuclear and plasma membrane receptors, leading to 
activation of the estrogenic signaling pathway. For instance the findings of a study conducted by  
Jain et al. [99] suggest that the gradual and sustained release of ionic cadmium may contribute to the 
metalloestrogenic effects of QDs with a cadmium core. Cd2+ may bind to ER to trigger estrogenic 
effects including nongenomic activation of MAPK and PI3K as well as genomic activation, which 
involves ER dimerization and binding to the estrogen response element to induce gene transcription. 
To confirm that the estrogenic signaling induced by QDs was mediated via the estrogen receptor, the 
Authors found that the addition of the selective estrogen receptor antagonist, ICI 182780, completely 
annulled all QD-induced estrogenic effects [99].  
The results of this study and the findings of Terzuoli [50], who suggested that the release of Ag+ 
under aqueous conditions could damage sperm membrane, endorse the idea that the release of ions by 
metallic NPs or QDs may play a relevant role in the induction of endocrine impairments in in vitro and 
in vivo models. Dissolution processes, consisting in the release of metallic cations, are greater in NPs 
than in bulk materials and are influenced by numerous factors such as reduced size, high  
surface-to-mass ratio, high radii of curvature, and corresponding low coordinated atoms at the  
surface [168]. This phenomenon is able to modify NP morphology and determine detrimental health 
effects [169–171]. In fact, different studies have demonstrated the correlation between NP toxicity and 
ions released from Ag-NPs [172–174], CdSe-QDs [175,176] and ZnO-NPs [170]. Therefore, the 
adverse effects on the endocrine system, potentially caused by the release of metal ions, should be 
more extensively evaluated in future studies. Moreover, NPs may also act by impairing the  
ligand-elicited signaling cascade as demonstrated by the direct interruption of insulin signaling in liver 
cells due to exposure to TiO2-NPs [110]. In this study, NPs reduced the phosphorylation on tyrosine 
residues of insulin receptor substrate proteins causing a decrease in the lipid messenger 
phosphatidylinositol 3,4,5 triphosphate wich is needed for most metabolic effects of insulin. The 
systematic identification of the molecular mechanisms that NPs may use to cause adverse effects on 
the endocrine system is particularly difficult because changes in their different physico-chemical 
properties may trigger different mechanisms of toxic action. Consequently, once more, accurate 
physico-chemical characterization of NPs seems essential in order to obtain a better understanding of 
the mechanisms of action.  
Toxicity testing of NPs using in vitro or in vivo assays is aimed at identifying a potential risk by 
establishing dose-response relationships that characterize this type of hazard. However, toxicological 
studies (even those that have investigated effects on the endocrine system), frequently use excessive 
and unrealistically high mass doses of NPs [177]. It is therefore debatable whether the findings 
observed in these studies can be extrapolated to refer to humans in realistic, lower exposure scenarios 
since the applied doses have little relevance to real-world conditions. Although it is not easy to 
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determine a realistic exposure dose to be used in these toxicological studies, as available data on 
exposure levels in workers and the general population are still very limited [20], it seems clear that 
future studies need to focus on the potentially adverse effects on the endocrine system of low-level NP 
exposure especially through the use of exposure doses similar to those identified in environmental 
monitoring studies. Furthermore, considering that in recent years additional metrics such as number 
concentration and surface area are being taken into account in the assessment of exposure to NPs [178], 
it would be interesting to express exposure doses also in terms of number concentration and surface 
area as has already been done in some studies [33–36,49,58,60,70,79,86,88,89,96]. 
The results of some studies involving the nature of the dose-response curve indicate that exposure 
to NPs may exert a hormetic response in endocrine organs. In fact, when evaluating changes in 
testosterone levels caused by NRDE-NPs, Li et al. [33] showed a clear inverted-U dose-response 
curve, while Ag-NPs were able to affect the TH-action on TRβ and RLKI transcripts according to an 
inverted-U hormesis response [105]. Hormesis has been observed in a number of studies that 
investigated the health effects of NPs and recently, Iavicoli et al. [24] have reviewed studies that reveal 
similar hormetic dose-responses in a variety of nanomaterials (e.g., single walled carbon nanotubes; 
silver molybdenum and aluminum nanoparticles, graphite nanofibers, titanium dioxide nanoparticles). 
However, at present, little is known of the reasons underlying possible NP induction of hormesis for 
some endpoints. Further research is therefore needed to better understand the physico-chemical 
properties of NPs that may induce hormesis, and the hazard endpoints that are most likely to be 
involved. It should be noted that factors such as aggregation and agglomeration can significantly 
influence NP characteristics in exposure and hazard studies [26]. In this context, a possible explanation 
of NP-induced hormesis may also lie in the aggregation of NPs at higher concentrations. Correct 
evaluation of this phenomenon therefore requires appropriate characterisation of the NPs in the test 
medium, since these can greatly influence the extent of particle agglomeration. Finally, to verify the 
actual presence of hormesis in NP dose-responses and interpret study findings, it might be helpful to 
apply the methodology suggested by Nascarella and Calabrese [24,179]. Summing up, future studies 
could provide invaluable information by ascertaining whether this particular phenomenon also occurs 
in other endocrine organs, or whether it is a result of exposure to other, different types of NPs. 
A critical issue concerning exposure to EDCs is the possibility that these substances may cause not 
only somatic but also intergenerational adverse effects on the endocrine system. In fact, in recent 
years, numerous studies have provided evidence that fetal or perinatal exposure to EDCs results in 
disturbed endocrine functions, especially in the sexual development of offspring [9]. In this context, 
some study findings have revealed that in utero exposure to CB-NPs and NRDE-NPs can also lead to 
testicular morphological and functional alterations in the male offspring of rats and mice [34,38]. 
Whether the toxic effects on pup gonads derived from direct NP action or were the result of alterations 
induced in the maternal endocrine/reproductive system is an open question. Therefore, since exposure 
to EDCs during critical periods of development may cause adverse consequences later in life,  
and since NPs may play a role as EDCs, future studies on the potential endocrine toxicity of NPs  
should also take into account the age, period of exposure and mechanisms of action of possible  
epigenetically-mediated intergenerational effects. 
Of all the studies on different types of NPs, it is those that have investigated possible adverse 
effects on the endocrine system due to DE-NPs that have provided the most intriguing results from an 
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environmental point of view. DE-NPs are the most common incidental combustion-derived NPs in the 
urban environment and can also occur in occupational settings [33]. The results of the studies  
reviewed [33,39,59–61,90,96] point to an endocrine disrupting activity on the part of DE-NPs, 
although lack of evidence regarding the relationship between the exposure doses used in the 
aforementioned studies and real environmental concentrations make it difficult to extrapolate these 
results to humans. Furthermore, since environmental contamination is generally due to a mixture of 
compounds, the disrupting effects of DE-NPs may be due to chemical substances around or attached to 
them which then exert an additive, synergic or antagonistic influence. It follows that further 
investigation on the toxicological profile of DE-NPs and the environmental pollutant mixture that 
generally envelops them is urgently needed in order to clarify their impact on endocrine function. 
The results of studies conducted on invertebrates provide valuable information for assessing the 
biota impact of NPs as endocrine disruptors. In fact, several parameters such as invertebrate growth 
and molting, changes in vitellogenin levels, and reduced fecundity are useful indicators of endocrine 
disruption activity. However, further research is also needed in this area to identify the endocrine 
disrupting mechanisms and thereby determine the specific biomarkers that would be effective in 
measuring these alterations. 
Finally, a complete and systematic assessment of the endocrine disrupting activity of NPs should be 
based on an analysis of the adverse effects they exert on the entire endocrine system. Currently, there 
is a lack of balance between studies that have evaluated their toxic effects on the male and female 
reproductive system and studies that have investigated the same effects on other endocrine organs such 
as the thyroid, neuroendocrine system, pituitary and adrenal glands (see Table 5).  
In conclusion, the data currently available indicate that several types of NPs can adversely affect the 
endocrine system, and in particular the male and female reproductive system. In fact, the results of the 
studies presented in this review suggest that NPs are able to disrupt the endocrine system by exerting 
cytotoxic effects and damaging the costituent cells of endocrine organs, thus influencing endocrine 
homeostasis, altering hormone byosinthesis, metabolism and release and interfering with the ligand 
elicited signaling. However, a more critical assessment of these findings suggests the need to interpret 
these results with caution since the information on the potential interations and toxicity of NPs on the 
endocrine system is quite limited and in some cases conflicting. This means it is not possible to to 
reach a broad and shared consensus on the role of NPs as endocrine disruptors on the basis of data 
currently available and further investigation is clearly required. Moreover, the current difficulty in 
reaching definitive conclusions on this topic is due to the heterogeneity of experimental study designs 
and to the numerous variables that can influence the toxicological profile of NPs. Obtaining an 
overview of results is complicated and challenging when quite different cell lines or laboratory 
animals, routes, times and doses of exposure (most of which are excessively high or not representative 
of a real human exposure) have been used in the studies reviewed. Clearly there is a need to establish a 
systematic and rational approach in the design of future studies. Moreover, the adverse effects of NPs 
on human health often depend on the chemical structure, shape, size, agglomeration state, surface area 
and functionalization of NPs. These are therefore among the factors to be considered in studying 
nanotoxic effects on the endocrine system. Finally, a key issue such as the molecular mechanisms 
underlying the potential endocrine toxicity of NPs is still largely unknown or unexplored. 
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It is hoped that this systematic review will provide helpful information and a stimulus for discussion 
on aspects that should be the focus of future studies. In our opinion, it is necessary to (i) carry out  
in vitro and in vivo studies using NPs whose chemical and physical properties have been characterized 
in a clear and detailed manner, (ii) clarify all the different potential molecular mechanisms of action 
underlying the adverse effects of NPs on endocrine organs, including those responsible for 
intergenerational effects (iii) study the biological responses of the endocrine system in relation to  
low-level exposures to NPs (iv) identify the presence of hormesis and (v) evaluate the endocrine 
disrupting effects of NPs on the entire endocrine system. 
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